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Summary 
Actin filaments are a fundamental component of the cytoskeleton. In eukaryotes, 
dynamic actin rearrangement plays a crucial part in cellular processes such as 
morphogenesis, adhesion, cell motility, cytokinesis and intracellular vesicle transport. 
Numerous aspects of actin dynamics in the cytoplasm of eukaryotic cells have been 
studied intensely over the past decades. Those studies revealed a very detailed 
knowledge about the structure and function of actin filaments as well as about the 
underlying mechanisms of F-actin formation.  
Though actin and proteins involved in actin assembly or disassembly have also been 
detected in the nuclei of many different eukaryotic cells lines, the detailed regulation 
and function of actin in the nuclear compartment is poorly defined. Monomeric 
nuclear actin was identified to participate in specific events such as transcriptional 
regulation or chromatin remodeling. Nevertheless, the existence and role of 
filamentous actin inside the nucleus has been controversially debated for years.  
Quite recently, specific actin probes have been described which enabled credible 
visualization of nuclear F-actin structures and provided a first insight into the 
regulation and function of actin polymerization in the nucleus. For example, a role for 
nuclear F-actin in response to DNA damage and efficient DNA repair as well as in the 
regulation of the SRF coactivator MRTF-A has been reported. Both events were shown 
to involve the assembly of nuclear actin filaments mediated by members of the formin 
family of actin nucleators.  
In this work, we provide evidence of a nuclear function of the disease associated 
formin INF2. We identified that activation of endogenous INF2 in the nucleus by means 
of INF2-DID-NLS or INF2-DAD-NLS expression mediated release of autoinhibition 
promotes the assembly of a nuclear F-actin network. We further observed that INF2 
mediated nuclear actin rearrangement efficiently regulates the translocation and 
activity of MRTF-A. Moreover, by deletion of INF2 using the CRISPR/Cas9 system as 
well as by siRNA mediated INF2 knockdown we could show that INF2-DAD-NLS driven 
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nuclear F-actin formation is primarily dependent on the presence of endogenous INF2. 
However, our data suggest concomitant modulation of nuclear mDia activity upon the 
release of INF2 autoinhibition in the nucleus.  
This study provides evidence for a role of the formin INF2 in the promotion and the 
formation of a nuclear actin network and thereby regulating the subcellular 
localization of MRTF-A and subsequent alteration of MRTF/SRF transcriptional activity.  
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Zusammenfassung 
Aktinfilamente sind ein wesentlicher Bestandteil des eukaryotischen Zellskeletts. Durch 
einen dynamischen Auf- und Abbau dieser Filamente werden zelluläre Vorgänge, wie 
etwa Morphogenese, Mobilität, Zellteilung oder der intrazelluläre Vesikeltransport, 
beeinflusst. Verschiedenste Faktoren, die bei dem dynamischen Umbau von 
Aktinfilamenten im Zytoplasma eine Rolle spielen, wurden in den letzten Jahren und 
Jahrzehnten ausgiebig studiert. Dank dieser Studien haben wir heute ein durchaus 
detailliertes, aber bei weitem nicht vollständiges Bild der genauen Struktur und 
Funktion von Aktinfilamenten, sowie der zugrundeliegenden Mechanismen, welche bei 
der Ausbildung eben dieser Filamente eine Rolle spielen. 
Interessanterweise wurden sowohl Aktin als auch einige weitere Proteine, welche 
üblicherweise am Auf- und Abbau von zytoplasmatischen Aktinfilamenten beteiligt 
sind, auch im Zellkern verschiedenster eukaryotischer Zelltypen nachgewiesen. Über 
die Regulierung und die Funktion von Aktin im Nukleus ist momentan allerdings nur 
sehr wenig bekannt. Beispielsweise wurde gezeigt, dass monomeres Aktin im Zellkern 
an der Umgestaltung von Chromatin beteiligt ist und die Gen-Transkription beeinflusst. 
Die Existenz und die Funktion von kernständigen Aktinfilamenten wurden jedoch von 
zahlreichen Forschergruppen über viele Jahre hinweg kontrovers diskutiert.  
Erst kürzlich konnten mithilfe spezifischer Aktin-bindender Sonden Aktinfilamente im 
Zellkern zuverlässig und überzeugend visualisiert werden. Dadurch wurden erstmals 
auch Details über ihre Regulierung und ihre Funktion im Nukleus bekannt. Zum Beispiel 
wurde gezeigt, dass kernständige Aktinfilamente eine wichtige Rolle bei der zellulären 
Antwort auf DNA-Schäden und der darauffolgenden DNA-Reparatur spielen. Zusätzlich 
sind sie in die Regulierung des MRTF/SRF-Signaltransduktionsweges involviert. Bei 
beiden genannten Prozessen wird die Bildung von kernständigen Aktinfilamenten 
durch Proteine aus der Familie der Formine begünstigt. 
Die vorliegende Doktorarbeit zeigt, dass auch das Formin INF2 zu Aktin-bezogenen 
Effekten im Nukleus führt. Beispielsweise löst die Expression einer isolierten, 
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kernständigen INF2-DID oder einer isolierten, kernständigen INF2-DAD eine spezifische 
Aktivierung von endogenem INF2 im Zellkern aus. Dadurch kommt es dort zur 
Aufhebung der Autoinhibierung von INF2, was wiederum zur Bildung von 
Aktinfilamenten im Nukleus führt. Außerdem haben wir beobachtet, dass der INF2-
gesteuerte Aufbau von kernständigen Aktinfilamenten eine Anreicherung des SRF-
Kofaktors MRTF-A im Zellkern bewirkt. Nach einer Reduktion oder einer vollständigen 
Deletion von INF2 in der Zelle kamen wir zu der Erkenntnis, dass die kernständigen 
Filamente, welche nach der Expression der INF2-DAD im Zellkern gebildet werden, 
primär vom Vorhandensein von endogenem INF2 abhängig sind. Unsere Daten weisen 
allerdings auch darauf hin, dass mittels dieser Methode zur INF2-Aktivierung neben 
kernständigem INF2 zusätzlich mDia-Formine im Nukleus koreguliert werden. 
Zusammengefasst beschreibt diese Arbeit, dass das Formin INF2 auch im Zellkern an 
der Bildung von Aktinfilamenten beteiligt ist und dass die Lokalisierung von MRTF-A 
sowie, in weiterer Folge, die transkriptionelle Aktivität des MRTF/SRF Signalwegs 
dadurch beeinflusst werden können.  
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1. Introduction 
The existence of a cytoskeleton was revealed in all three domains of life (prokaryotic, 
eukaryotic and archaea) where it forms an intracellular filamentous scaffold 
(Wickstead and Gull, 2011). It is in charge of a wide variety of fundamental features 
such as providing mechanical resistance to deformation, defining the cellular shape 
and mechanics during processes like migration and cytokinesis, linking the cell 
physically and biochemically to the extracellular matrix, organizing the contents of the 
cells or intracellular cargo transport. Three main classes of cytoskeletal structures have 
been described in eukaryotes: actin filaments, microtubules and the heterogeneous 
group of intermediate filaments. In general, cytoskeletal structures are dynamically 
and adaptively modulated by the assembly or disassembly of monomeric subunits into 
polymers and vice versa, mediated by numerous regulatory and structural proteins 
(Fletcher and Mullins, 2010).  
In the last decades, studies addressing components of the cytoskeleton revealed 
numerous details and information concerning their structures, functions as well as 
their mechanisms of formation. In contrast, there is only a minor knowledge about the 
rather vaguely defined ‘nucleoskeleton’ (Simon and Wilson, 2011). The general 
concept of the term nucleoskeleton includes the composition and function of the 
nuclear architecture involved in processes such as maintaining the nuclear shape, gene 
expression, chromatin remodeling, DNA processing, cell signaling and of course the 
dynamic reorganization, for instance during mitosis. The nucleoskeleton is mainly 
composed of lamin filaments, actin, multisubunit proteins and the genome (Dahl and 
Kalinowski, 2011). It is connected to the cytoskeleton through the LINC complex which 
transmits mechanical stimuli and signaling cues from the cytoplasm to the nucleus and 
vice versa (Ostlund et al., 2009).  
Actin was shown to be a key component in both nucleo- and cytoskeleton, although it 
might be differentially organized and regulated and might fulfill differing functions in 
the nucleus and the cytoplasm. Many previous studies proposed the existence of actin 
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in the nucleus solely in a monomeric or short oligomeric state, rather executing 
regulatory or accessory functions than structural or mechanical tasks (Pederson, 2008; 
Pederson and Aebi, 2002). However, quite recently, long nuclear actin filaments could 
be visualized within somatic cell nuclei, together with first insights into nuclear F-actin 
regulation and function (Baarlink et al., 2013; Belin et al., 2013; Plessner et al., 2015). 
Nevertheless, further exploration of nuclear actin and nuclear actin binding proteins is 
needed to fill the gaps in our current understanding of the regulatory mechanistic and 
functions of F-actin in the nucleus. 
 
1.1 The actin cytoskeleton 
Among the three types of cytoskeletal filamentous structures, actin filaments form the 
thinnest with a diameter of 5 – 9 nm (Holmes et al., 1990). Multiple F-actin cross-
linking proteins can organize actin filaments into bundles or network like structures 
(Dubreuil, 1991; Tseng et al., 2005; Tseng et al., 2002). These higher-order actin 
structures can shape into multiple varying intracellular structures such as stress fibers 
or cortical actin, as well as into cellular extensions as microvilli (DeRosier and Tilney, 
2000), podosomes (Gimona et al., 2008), filopodia (Mattila and Lappalainen, 2008), 
lamellipodia (Small et al., 2002) or membrane blebs (Fackler and Grosse, 2008). Due to 
their diversity, various actin structures can fulfill a wide variety of cellular functions, 
such as cytokinesis, cell adhesion, cell contraction, cell migration, intracellular 
transport as well as the regulation of cell-cell contacts, cell polarity and cell shape 
(Dominguez and Holmes, 2011; Glotzer, 2001; Olson and Sahai, 2009; Pollard and 
Cooper, 2009). Furthermore, a function of actin in the regulation of gene transcription 
has been described (Bunnell et al., 2011; Louvet and Percipalle, 2009; Olson and 
Nordheim, 2010).  
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1.1.1 Actin assembly and disassembly 
The highly conserved cytoskeletal component actin is one of the most abundant 
proteins in eukaryotic cells (Dominguez and Holmes, 2011). Mammalians express six 
different actin isoforms. Each isoform is encoded by a separate gene and carries out 
unique cellular functions. Two of those six isoforms, namely β-cyto-actin and γ-cyto-
actin, are ubiquitously expressed, whereas the remaining four isoforms, α-skeletal-
actin, α-cardiac-actin, α-smooth-actin and γ-smooth-actin, are expressed primarily in 
skeletal, cardiac or smooth muscle cells (Perrin and Ervasti, 2010).  
Actin exists in two different forms inside cells, either as globular monomer (G-actin) or 
as polymerized filamentous structure (F-actin), forming a twisted double helix (Holmes 
et al., 1990). The 42 kDa large actin monomers are composed of four subdomains with 
an ATP/ADP binding cleft (Otterbein et al., 2001). During F-actin assembly, ATP-bound 
G-actin gets incorporated into the polymeric F-actin structure at the so called barbed 
end (plus end), with its ATP/ADP binding cleft directed to the pointed end (minus end), 
thus leading to structural polarity of F-actin (Begg et al., 1978; Dominguez and Holmes, 
2011; Wegner and Isenberg, 1983). As actin also possesses an ATPase function, ATP 
gets hydrolyzed upon incorporation of the actin monomer into the growing filament. 
Thus, the actin filament contains just ADP after some time at the pointed end. As F-
actin which binds ADP is less stable than that binding ATP, the filament gets 
depolymerized at the pointed end (Dominguez and Holmes, 2011). This constant 
process of dissociation of actin monomers from the pointed end and simultaneous 
incorporation of G-actin at the barbed end is called actin treadmilling (Bugyi and 
Carlier, 2010).  
To maintain an equilibrium between assembly and disassembly of actin filaments at 
steady state conditions or to modulate F-actin formation or depolymerization upon 
diverse cell signaling events multiple additional proteins were described to interact 
with actin structures (Figure 1). For example, several capping proteins, such as F-actin 
capping protein or gelsolin, were discovered that bind to the barbed end of F-actin and 
thus prevent elongation of the filament (Kim et al., 2010; Sun et al., 1999). To 
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modulate disassembly of actin filaments, capping proteins such as tropomodulin can 
also bind to the filament’s pointed end (Pollard et al., 2000; Weber et al., 1994). 
Proteins as profilin for instance were shown to form a complex with ATP bound G-actin 
and bind to the barbed end, thereby enhancing the elongation of F-actin (Pollard et al., 
2000; Pring et al., 1992). Contrariwise, severing proteins, such as members of the actin 
depolymerizing factor (ADF)/cofilin family, promote depolymerization of actin 
filaments at the pointed end (Theriot, 1997).  
 
Figure 1: Regulation of actin turnover 
The twisted double-helical actin filament is assembled by adding ATP-bound G-actin to the barbed end. 
Upon hydrolysis of ATP to ADP the filament is destabilized and facilitates the binding of severing 
proteins such as ADF. This results in depolymerization of F-actin at the pointed end and free ADP-bound 
G-actin. ADP-actin monomers can then be recycled through nucleotide exchange. Profilin then either 
binds directly to ATP-actin monomers or, with a lesser affinity, to ADP-G-actin, thereby promoting 
nucleotide exchange. Subsequently, profilin directs ATP-bound actin monomers to free barbed ends. 
Capping proteins prevent binding of G-actin to the barbed end and thus inhibit the filament from being 
elongated. The image was adapted from (Le Clainche and Carlier, 2008).  
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1.2 Regulation of actin nucleation and elongation 
The initial assembly of actin filaments from G-actin requires the formation of a trimeric 
actin complex. This process is called actin nucleation. Although it was shown in vitro 
that purified G-actin can self-assemble into F-actin, spontaneous nucleation is 
kinetically unfavorable and is the rate-limiting step in actin polymerization 
(Campellone and Welch, 2010; Sept and McCammon, 2001).  
Until now, three main classes of proteins, so called actin nucleating factors, have been 
identified that overcome the need for spontaneous actin nucleation and drive the 
rapid initiation of de novo actin filament assembly: (1) the Arp2/3 (actin-related 
protein 2/3) complex together with nucleation-promoting factors (NPFs) (Goley and 
Welch, 2006; Stradal and Scita, 2006), (2) tandem-monomer-binding nucleators (Ahuja 
et al., 2007; Quinlan et al., 2005) and (3) formins (Pruyne et al., 2002) (Figure 2). The 
multiple classes of actin nucleators give the cell the flexibility to assemble distinct 
populations of actin filaments in response to specific signals in different cellular 
locations.  
The highly conserved nucleating factor Arp2/3 is a complex composed of seven 
subunits, namely Arp2, Arp3 and ARPC1 – ARPC5 (Machesky et al., 1994; Robinson et 
al., 2001). Arp2/3 binds laterally of an already existing actin filament and initiates the 
formation of a new branched filament at a 70° angle (Blanchoin et al., 2000; Mullins et 
al., 1998). Thereby, Arp2 and Arp3 act as the first two subunits of the newly formed 
filament (Volkmann et al., 2001). However, the Arp2/3 complex itself is not able to 
nucleate actin efficiently. Thus, the Arp2/3 complex requires additional regulatory 
proteins, NPFs, to initiate formation of a branched actin filament. At the C-terminus, 
NPFs usually contain three motifs: a verprolin-homology domain, also known as WASP-
homology 2 (WH2) domain, a connector region and an acidic motif. This region is 
therefore termed VCA-domain and binds to actin via its V motif, as well as to the 
Arp2/3 complex via C and A (Welch and Mullins, 2002). NPFs also contain an N-
terminal GTPase-binding domain (GBD) which interact with the C motif and thus 
autoinhibits the protein. Upon activation by Rho-GTPases, for example CDC42 and 
 15 
 
Rac1, together with phosphatidylinositol-4,5-bisphosphate (PIP2), autoinhibition is 
released, the free VCA domain can bind to Arp2/3 and actin and start actin 
polymerization subsequently (Bi and Zigmond, 1999; Prehoda et al., 2000). The family 
of NPFs include proteins such as WASP, N-WASP (a neuronally expressed form of 
WASP), WAVE/SCAR, WASH or WHAMM (Rotty et al., 2013).  
 
Figure 2: Three classes of actin nucleating factors promote F-actin assembly 
A) The initiation of F-actin assembly requires the formation of a trimeric actin nucleus. The actin dimer 
and trimer intermediate is very unstable, therefore spontaneous nucleation is kinetically unfavorable 
and requires actin nucleating factors. B) The ARP2/3 complex, in the presence of NPFs, promotes actin 
nucleation after binding to a pre-existing actin filament and generates branched actin filaments at a 70° 
angle. Members of the family of tandem-monomer-binding nucleators recruit actin monomers and 
 16 
 
assemble and stabilize actin nucleation seeds. This cartoon illustrates cordon bleu which nucleates a 
filament by assembling and stabilizing an actin trimer. It might remain associated with the pointed end 
of F-actin during elongation. W: WH2 domain, L: linker region. Formins drive the nucleation of long, 
unbranched filaments. During elongation, they remain associated and move along the barbed end and 
deliver profilin-bound G-actin. The image was adapted from (Weston et al., 2012).  
The second class of actin nucleating factors termed tandem-monomer-binding 
nucleators was recently identified and includes for example the proteins spire, cordon-
bleu (cobl) and leiomodin (lmod) (Ahuja et al., 2007; Chereau et al., 2008; Quinlan et 
al., 2005). These proteins possess one (lmod) or more (cobl: 3, Spire: 4) WH2 domains 
separated by short linker sequences or, as lmod, additional actin binding domains, 
thereby recruiting actin monomers and forming actin polymerization seeds (Chesarone 
and Goode, 2009).  
 
1.3 Formins 
The multidomain protein family of formins, which are present in almost all eukaryotes, 
represents the third class of actin nucleating factors. They promote the nucleation and 
elongation of unbranched actin filaments (Pruyne et al., 2002). Phylogenetic analysis of 
the highly conserved formin homology 2 (FH2) domain revealed that Metazoan 
formins can be segregated into seven groups: Dia (diaphanous), Daam (dishevelled-
associated activator of morphogenesis), FMNL (formin-like protein) or FRL (formin-
related gene in leukocytes), FHOD (formin homology domain-containing protein), INF 
(inverted formin), FMN (formin) and Delphilin. Most groups contain multiple members, 
for example mammals have 15 identified formin genes in total (Table 1) and therefore 
formins represent the largest group of actin nucleators (Breitsprecher and Goode, 
2013; Higgs, 2005).  
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Table 1: Mammalian formin members 
Subfamily Members 
Dia mDia1  (DIAPH1) 
mDia2  (DIAPH3) 
mDia3   (DIAPH2) 
Daam Daam1 
Daam2 
FMNL FMNL1 (FRL1) 
FMNL2  (FRL3, FHOD2) 
FMNL3  (FRL2) 
FHOD FHOD1 
FHOD2  (FMNL2) 
FHOD3 
INF INF1 
INF2 
FMN FMN1 
FMN2 
Delphilin Delphilin 
 
Formins are mainly defined by two regions: the formin homology 2 (FH2) domain and 
the formin homology 1 (FH1) domain. The catalytic FH2 domain is required for 
association with the barbed end of growing actin filaments and promotes processive 
actin assembly (Higashida et al., 2004; Pring et al., 2003; Pruyne et al., 2002) . The 
proline-rich FH1 domain precedes the FH2 domain and binds profilin-actin to 
accelerate actin filament elongation (Kovar and Pollard, 2004; Paul et al., 2008).  
The most intensely investigated formins belong to the domain-based classification 
group of Diaphanous-related formins (DRFs), which share a highly conserved domain 
architecture among diverse model organisms (Breitsprecher and Goode, 2013). Briefly, 
prototypic DRFs (including Dia, Daam and FMNL) feature an N-terminal regulatory 
region and a C-terminal activity region. The N-terminal FH3 subdomain diaphanous 
inhibitory domain (DID), consisting of five armadillo repeats, and the C-terminal 
diaphanous autoregulatory domain (DAD) interact in an autoinhibitory manner (Figure 
4A). Activated Rho-GTPases can relieve this intramolecular inhibition by interacting 
with the N-terminal GBD (Li and Higgs, 2005; Otomo et al., 2005a; Rose et al., 2005). 
Upon activation, the FH2 domain forms an antiparallel dimer and subsequently 
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promotes incorporation of monomeric actin into the growing barbed end of filament 
(Xu et al., 2004). 
Besides DRFs, formins differ strikingly in their domain organization (Figure 3) 
(Campellone and Welch, 2010). For example, FMN1 and FMN2 possess a formin-spire 
interaction domain (FSI) (Vizcarra et al., 2011) and delphilin contains a PDZ domain 
(Miyagi et al., 2002).  
 
Figure 3: Representative formins of each metazoan subgroup show distinct domain organization 
The cartoon illustrates similarities and differences in the domain organization of representative 
members from each metazoan formin group. All formins share a conserved FH1 and FH2 domain. CC: 
coiled coil; DAD: diaphanous-autoinhibitory-domain; DD: dimerization domain; FSI: formin–Spire 
interaction domain; PDZ: Postsynaptic density protein, Discs large, Zona occludens 1 domain. The image 
was adapted from (Campellone and Welch, 2010; Goode and Eck, 2007). 
 
1.3.1 Formin induced actin assembly 
Although detailed information about mechanism, regulation and function of diverse 
formins became available within the last decade, the precise actin nucleation 
procedure still has to be determined. It was initially suggested that spontaneously 
formed actin dimers and trimers are captured and stabilized by the FH2 domain and 
filaments are assembled subsequently (Pring et al., 2003).  However, in vivo, the pool 
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of G-actin is predominantly bound to profilin, which inhibits spontaneous formation of 
an actin nucleus and thus would make formin-mediated F-actin formation a rather rare 
event (Chesarone and Goode, 2009). More recently, studies suggested that C-terminal 
of the FH2 domain located sequences play a role in – either direct or indirect – 
recruiting actin monomers and promoting actin nucleation (Chhabra and Higgs, 2006; 
Gould et al., 2011; Heimsath and Higgs, 2012; Thompson et al., 2013).  
Upon actin nucleation, the dimeric FH2 domain processively associates with the 
barbed end of F-actin and permanently incorporates new actin subunits before it 
dissociates (Otomo et al., 2005b). Additionally, it prevents termination of F-actin 
elongation by inhibiting the binding of other capping proteins to the barbed end 
(Zigmond et al., 2003). The processive movement along the barbed end of F-actin was 
suggested to involve transient, alternating interaction of the two dimerized FH2 
domains with the two terminal F-actin subunits. Thereby, the FH2 dimer was 
suggested to switch between a closed conformation where both FH2 domains are 
bound to actin subunits, preventing addition of new actin monomers and an open 
conformation allowing filament elongation (Otomo et al., 2005b; Paul and Pollard, 
2009).  
In contrast to the slow elongation rate at free barbed ends, the rate at the FH2 bound 
barbed end is enhanced massively due to the interaction of the FH2 adjacent FH1 
domain with profilin bound G-actin (Kovar, 2006; Paul et al., 2008; Romero et al., 
2004). The proline rich FH1 domain is thought to recruit multiple profilin-actin 
complexes, thereby increasing the local concentration of G-actin at the barbed end 
with subsequent incorporation into the growing filament (Vavylonis et al., 2006). 
However, the exact mechanism how actin subunits are delivered from the FH1 to the 
FH2 domain still has to be elucidated. It might be dependent on direct interactions 
between profilin-actin as well as the FH1 and FH2 domain (Neidt et al., 2009). 
In vitro, formins remain attached to the barbed end for minutes without dissociating, 
thereby assembling actin filaments much longer than they could ever be detected in 
living cells (Kovar et al., 2006; Neidt et al., 2008). Thus, in vivo regulatory mechanisms 
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are needed to displace formins from the barbed end and stop formin mediated 
filament elongation. Such mechanisms have been identified for S. cerevisiae. For 
example, Bud14 catalyzes the rapid displacement of the yeast formin Bnr1 (Chesarone 
et al., 2009) and Smy1 interferes with elongation of F-actin by binding to the FH2 
domain of Bnr1 (Chesarone-Cataldo et al., 2011). Additionally, it has been shown that 
the Arp2/3 complex and WAVE can directly inhibit mDia2 mediated filopodia formation 
(Beli et al., 2008).  
 
Figure 4: A model of formin-mediated actin polymerization 
A) Crystal structure of the dimeric FH2 domain of FMNL3 bound to two subunits of actin. The image was 
taken and adapted from the RSCB Protein Data Bank (PDB ID: 4EAH), originally published by (Thompson 
et al., 2013). B) A model for formin-mediated actin assembly. (1) The FH2 dimer processively associates 
with the barbed end of F-actin. In an initial closed conformation, both FH1 domains recruit profilin 
bound G-actin. (2) Upon delivery of profilin-actin to the barbed end by FH1, the adjacent FH2 domain 
moves along the barbed end. (3) The process is repeated by the second FH2 domain. (4) Back in a closed 
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conformation, the filament is prevented by binding of other factors. The image was adapted from 
(Campellone and Welch, 2010). 
 
1.3.2 Regulation of formin proteins 
Autoinhibition of DRFs is mediated by binding of the N-terminal DID with the C-
terminal DAD (Alberts, 2001; Li and Higgs, 2005). Two main motifs in the DAD play an 
important role in the autoinhibition mechanism: an amphipathic helix followed by a 
sequence rich in basic residues. Co-crystallization of mDia1-DID together with mDia1-
DAD revealed binding of the entire DAD polypeptide to the DID, more precisely to the 
central B helices of the five armadillo repeats at the concave surface, through 
numerous mainly hydrophobic contacts (Alberts, 2001; Nezami et al., 2006) (Figure 
5A). Interaction of the DID and DAD was shown to prevent F-actin elongation mediated 
by the activity of the FH2 domain through a proposed steric contact inhibition of FH2 
and actin (Nezami et al., 2010; Otomo et al., 2010). Noteworthy, it has also been 
hypothesized for DRFs that autoinhibition does not occur intramolecular but rather in 
dimeric or higher order configurations (Copeland et al., 2007).  
Beside the modulation of DRFs by its DID/DAD mediated autoinhibition, other 
regulatory mechanisms have been described which interfere with the catalytic activity 
of the FH2 domain. One example is dia-interacting protein (DIP) which was shown to 
interact with the FH1 and FH2 domains of mDia2 and modulates cortical actin 
assembly (Eisenmann et al., 2007).  
In general, Rho-GTPases, which belong to the Ras family of small GTPases, have been 
shown to play crucial roles in the regulation of actin remodeling. For example, they are 
involved in actin stress fiber formation (Rho) as well as in the formation of lamellipodia 
(Rac) or filopodia (Cdc42) (Jaffe and Hall, 2005). Briefly, Rho-GTPases function as 
molecular switches. They cycle between a GTP-bound active and a GDP-bound inactive 
state. This cycling activity is modulated by guanine nucleotide exchange factors (GEFs), 
which promote Rho activation through the exchange of GDP to GTP, as well as by 
 22 
 
GTPase-activating proteins (GAPs), which mediate inactivation of Rho by stimulating its 
intrinsic GTPase activity. In an active state, Rho-GTPases fulfill their regulatory 
functions through interaction with effector proteins (Jaffe and Hall, 2005).  
The impact of Rho-GTPases on actin rearrangement is partially mediated through 
formins, which constitute the largest protein family of Rho effectors. Upon stimulation 
by extracellular signals, for example serum or lysophosphatidic acid (LPA), G-protein-
coupled receptors (GPCRs) get activated (Young and Copeland, 2010). Subsequently, 
they stimulate RhoGEFs, such as LARG for example which in turn promotes RhoA 
activation to release autoinhibition of mDia1 (Fukuhara et al., 2000; Goulimari et al., 
2008).  
Binding of activated members from the Rho-GTPase family to the GBD releases the 
autoinhibition of DRFs (Figure 5B) (Lammers et al., 2005). In the case of mDia1, 
activated RhoA binds to the GBD-DID fragment. A model suggests that RhoA sterically 
interferes via Arg68 with the DAD binding to the DID. Additionally, RhoA binding also 
stabilizes the position of the GBD relative to the DID and thus a six residue segment of 
the GBD directly occludes the DAD binding site (Nezami et al., 2006) (Figure 5C).  
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Figure 5: Regulation of DRF autoinhibition 
A) This ribbon model illustrates the overall structure of the mDia1-DID/DAD complex in an mDia1-
autoinhibited state. The DID is shown in blue, the DAD is shown in yellow. The N and C termini of the 
DAD domain are indicated and the B helices of the armadillo repeats are labeled from left to right. The 
image was taken from (Nezami et al., 2006). B) DRFs (here: mDia1) are autoinhibited by an 
intramolecular interaction between DID and DAD. Upon stimulation by binding of Rho-GTPases, the 
autoinhibition is released and formins get activated. The image was adapted from (Goode and Eck, 
2007) C) This close-up ribbon model demonstrates the steric masking of the mDia1 DAD binding site by 
the Rho complex (shown in green). GBD (red) residues 92-97 and Rho residue R68 impact binding of the 
N-terminus of the DAD (superimposed in yellow) to the DID (purple). Thus, binding of Rho, together with 
the restructured GBD excludes simultaneous binding of the DAD and drives activation of the formin. The 
image was taken from (Nezami et al., 2006). 
The activation of formins to mediate diverse biological functions requires distinct Rho-
GTPases. For example, mDia2 is activated by the Rho-GTPase Rif to induce filopodia 
(Pellegrin and Mellor, 2005), whereas during endosomal trafficking it is activated by 
RhoB (Wallar et al., 2007). Moreover, Rac1 has also be reported to be able to regulate 
mDia2 (Ji et al., 2008). In turn, each Rho-GTPase can act on different formins to carry 
out diverse biological functions. This is also dependent on the cellular context as well 
as on the intracellular localization. As an example, Cdc42 activates mDia2 at the 
leading edge of the cell (Peng et al., 2003), whereas it modulates FMNL1 (also referred 
to as Frlα) during formation of phagocytic cups (Seth et al., 2006).  
However, the process of formin activation is a quite complex interplay between 
different proteins and therefore is yet not fully understood. For example it was shown 
that the FH2 domain of mDia1 binds to LARG and thus is able to activate RhoA in a 
positive feedback loop (Kitzing et al., 2007). It was also shown that other factors than 
Rho-GTPases are involved in the activation of formins. Autoinhibition of Daam1 for 
instance was shown to be regulated by interaction with a PDZ domain of Dishevelled, a 
member of the noncanonical Wnt signaling pathway. This interaction for full activation 
of Daam1 either occurs independently or together with Rho (Liu et al., 2008).  
Additionally, the release of formin autoinhibition as well as their intracellular 
localization can be mediated by post-translational modifications such as 
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phosphorylation. For example, Protein kinase Cα (PKCα) phosphorylates FMNL2 within 
the DAD domain, thereby regulating its localization and activity (Wang et al., 2015). 
Furthermore, the autoinhibition of FHOD1 can be disrupted by Rho associated coiled 
coil containing protein kinase (ROCK) mediated phosphorylation at three conserved 
residues in the polybasic region C-terminal of the DAD, resulting in the formation of 
stress fibers (Takeya et al., 2008). ROCK was additionally shown to phosphorylate 
residues in the C-terminus of a muscle specific FHOD3 isoform, leading to activation 
and subsequent increased F-actin assembly in cardiomyocytes (Iskratsch et al., 2013). 
In turn, casein kinase 2 (CK2) phosphorylates a site in the FH2 domain of this muscle 
specific FHOD3 splice variant which targets the formin to the myofibrils in 
cardiomyocytes (Iskratsch et al., 2010). Moreover, Aurora B kinase phosphorylates 
residues in FHOD1, thereby regulating actin cables after cell division (Floyd et al., 
2013). Aurora B kinase also phosphorylates the FH2-domain of mDia3, which inhibits 
its ability to stabilize microtubules (Cheng et al., 2011). Furthermore, formins were 
shown to be post-translationally modified through the attachment of lipid molecules. 
For example, the formin subfamily of FMNL proteins is N-terminally myristoylated, 
which regulates its membrane trafficking (Han et al., 2009). Moreover, binding of 
phospholipids to the N-terminus of mDia1 was suggested to anchor formins at the 
plasma membrane whereas an interaction with phospholipids in the mDia1 C-terminus 
might provide a switch for transient inactivation (Ramalingam et al., 2010).  
 
1.3.3 Cellular function of formins 
Formins have been described intensely over the last decade (Baarlink et al., 2010; 
Goode and Eck, 2007; Wallar and Alberts, 2003). They play an essential role in diverse 
cellular processes such as cell and tissue morphogenesis. For example Daam1 was 
shown to be essential for Wnt/Frizzled mediated RhoA activation during Xenopus 
gastrulation (Habas et al., 2001). Furthermore, formins can drive cell motility as it was 
shown during amoeboid cell migration, where FMNL2 modulates invasiveness of cells 
(Kitzing et al., 2010). FMNL2 is also involved in the trafficking of β1-integrin, thus 
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modulating invasion (Wang et al., 2015). Formins additionally participate in the 
formation of cell-to-cell contacts. For instance, FMNL2 was shown to modulate 
junctional actin assembly and turnover (Grikscheit et al., 2015). Additionally, formins 
were shown to be essential during cytokinesis, where mDia2 drives F-actin formation 
to assemble a scaffold for the contractile ring and stabilizes its position during 
cytokinesis (Watanabe et al., 2008). Moreover, it was described in Drosophila that 
mutations in the formin diaphanous lead to a failure in cell division during 
spermatogenesis and multinucleated spermatids (Castrillon and Wasserman, 1994). 
Studies in Drosophila revealed further critical functions of formins, such as the 
maintenance of cell polarity and regulation of embryonic development. For example, 
the Drosophila formin cappuccino is required for the polarity of fly eggs and embryos 
(Emmons et al., 1995). Furthermore, in the Drosophila respiratory system, Daam 
regulates the tracheal cuticle pattern through arranging the actin cytoskeleton 
(Matusek et al., 2006). Moreover, vesicular transport was also shown to be dependent 
on the function of formins, such as the human isoform hDia2C, which regulate 
endosomal dynamics (Gasman et al., 2003).  
Besides their role in rearrangement of actin structures, formins possess also an impact 
on microtubule networks. For example it was described that loss of FMN2 in mouse 
oocytes results in failed meiotic spindle alignment and fertility (Leader et al., 2002). 
Furthermore, mDia3 is s required for microtubule attachment to the kinetochore and 
proper chromosome segregation (Yasuda et al., 2004), whereas mDia1 plays a role in 
the orientation and coordination of microtubules (Goulimari et al., 2008; Ishizaki et al., 
2001).  
Another relevant function of formins is their impact on serum response factor (SRF) 
dependent transcriptional regulation, modulated through formin mediated actin 
rearrangement (Copeland and Treisman, 2002; Copeland et al., 2007; Grosse et al., 
2003).  
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1.4 Regulation of the MRTF/SRF transcriptional pathway 
The transcription factor SRF is abundantly expressed in many different cell types 
among diverse species, from yeast to human (Norman et al., 1988; Olson and 
Nordheim, 2010; Shore and Sharrocks, 1995). SRF binds as a homodimer with high 
affinity to a palindromic CArG-box DNA sequence, also named serum response 
element (SRE) and promotes transcription of numerous target genes (Treisman, 1986). 
SRF activity is competitively modulated through binding of two different types of 
cofactors, the ternary complex factors (TCFs) (Buchwalter et al., 2004) as well as the 
MRTF family of co-activators (myocardin and myocardin-related transcription factors - 
MRTFs) (Pipes et al., 2006; Wang et al., 2001; Wang et al., 2002). Both cofactors are 
differentially signal regulated and enable SRF to drive transcription of different sets of 
target genes in a competitive manner (Gualdrini et al., 2016). While TCFs respond to 
signals of the mitogen-activated protein kinase (MAPK) pathway, MRTF mediated 
transcription is dependent on the rearrangement of the actin cytoskeleton (Gineitis 
and Treisman, 2001; Zaromytidou et al., 2006). SRF was shown to be essential for 
numerous biological processes including development of the heart and the 
cardiovascular system, liver development, activity of T-cells and B-cells, gastrulation, 
brain development and many more (Olson and Nordheim, 2010). Most of those 
developmental defects can be explained at least in part by functional defects of actin 
cytoskeleton dynamics (Schratt et al., 2002).  
The MRTF family includes the transcriptional co-activators myocardin which is 
expressed specifically in the cardiovascular system, as well as the more widely 
expressed MRTF-A (also known as MAL, MKL1 and BSAC) and MRTF-B (also known as 
MKL2 and MAL16) (Wang et al., 2001; Wang et al., 2002). MRTFs interact with SRF 
through a basic region and an adjacent localized Glutamic-acid-rich domain (Olson and 
Nordheim, 2010). At the N-terminus, MRTF-A and MRTF-B possess three so called RPEL 
domains (Arg-Pro-X-X-X-Glu-Leu), which form a stable complex with G-actin. In 
contrast, the RPEL of myocardin differs from that of MRTF-A and MRTF-B and does not 
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bind monomeric actin efficiently (Guettler et al., 2008; Miralles et al., 2003; Pipes et 
al., 2006).  
In cells featuring low actin polymerization states the pool of G-actin is relatively high 
compared to F-actin. Thus, MRTF proteins form a reversible complex with G-actin and 
therefore exist in an inactive state sequestered in the cytoplasm (Posern et al., 2002). 
However, initiation of F-actin assembly, for example by formins (Copeland and 
Treisman, 2002), reduces the availability of G-actin through its incorporation into 
newly formed filaments. G-actin then dissociates from MRTFs, which promotes release 
of an nuclear localization sequence (NLS) within the RPEL motif (Pawłowski et al., 
2010) and allows subsequent nuclear import of MRTFs followed by activation of SRF 
dependent gene transcription (Miralles et al., 2003). Additionally, MRTF activity is also 
regulated by G-actin inside the nucleus. It was shown that nuclear export of MRTF is 
driven by nuclear actin monomers. Furthermore, the nuclear G-actin pool prevents 
MRTF to activate SRF (Vartiainen et al., 2007). 
Studies have revealed more than 200 target genes which are directly regulated by SRF 
(Cooper et al., 2007). Thereby, TCF and MRTF mediated co-activation differs in terms 
of SRF target gene expression. TCF modulated target genes encoding proteins with so 
called immediate-early functions, for example proteins involved in cell cycle 
progression. MRTF-regulated target genes for instance play a role in muscle-specific 
contractile functions or actin rearrangement and therefore in processes such as 
proliferation and cell motility (Buchwalter et al., 2004; Medjkane et al., 2009; Olson 
and Nordheim, 2010). Interestingly, actin itself was also shown to be a target gene of 
MRTF/SRF regulated gene expression (Olson and Nordheim, 2010). Thus, 
nucleocytoplasmic shuttling of MRTF is additionally regulated by a negative feedback 
loop, as ongoing synthesis of actin results in increased levels of cytoplasmic and 
nuclear G-actin and subsequent impairment of SRF activity.  
 
 
 28 
 
1.5 Actin and actin binding proteins in the nucleus 
The localization of actin in the nuclear compartment as well as its underlying 
nucleocytoplasmic shuttling mechanism was previously reported. G-actin is imported 
as a complex with cofilin in an importin 9-dependent manner (Dopie et al., 2012) and 
gets exported together with profilin by the export receptor exportin 6 (Stüven et al., 
2003; Wada et al., 1998).  
The appearance and diverse functions of monomeric and short oligomeric actin in the 
nucleus was already widely accepted and described. For example, as already 
mentioned, actin in the nucleus is implicated in specific regulation of the MRTF/SRF 
transcriptional pathway (Vartiainen et al., 2007). Moreover, multiple studies revealed a 
role for actin in the regulation of general eukaryotic gene transcription as well as 
chromatin remodeling (de Lanerolle and Serebryannyy, 2011). For instance, nuclear 
actin was reported to interact with all three RNA polymerases, Pol I (Philimonenko et 
al., 2004), Pol II (Hofmann et al., 2004) and Pol III (Hu et al., 2004), and thus may affect 
their transcriptional function. Actin was also shown to interact in the nucleus with the 
BAF chromatin-remodeling complex (Zhao et al., 1998). Moreover, it regulates the 
remodeling activity of the yeast INO80 chromatin remodeling complex in its 
monomeric form (Kapoor et al., 2013).  
Furthermore, actin-binding proteins were reported to play a role in general regulation 
of gene transcription. For example, the Arp2/3 complex in association with N-WASP 
has been implicated in transcriptional regulation of RNA polymerase II (Wu et al., 2006; 
Yoo et al., 2007). Moreover, nuclear myosin I (NM1) has been described to affect 
transcription mediated by RNA polymerase I and II (Hofmann et al., 2006; 
Philimonenko et al., 2004; Ye et al., 2008). Also several actin-related proteins, sharing 
the basal actin-structure but possess functions different from actin, were detected to 
be functional components of the transcription complex as well as chromatin 
remodeling complexes (Fenn et al., 2011; Harata et al., 2002; Lee et al., 2007; Szerlong 
et al., 2008; Zhao et al., 1998).  
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Interestingly, actin was mostly shown to act in a monomeric or short oligomeric state 
on nuclear complexes (Grosse and Vartiainen, 2013; Percipalle, 2013). However, 
photobleaching experiments suggested the existence of at least three different actin 
pools in the nucleoplasm which may correspond to a monomeric and a polymeric actin 
state as well as actin bound to functional complexes (McDonald et al., 2006). 
Furthermore, drug mediated prevention of actin polymerization and utilization of a 
polymerization deficient actin-mutant reduced RNA polymerase I mediated 
transcription in vitro and in vivo (Ye et al., 2008), thus arguing for the requirement of 
polymerized actin for gene transcription. Nevertheless, the question whether the 
localization and identified functions of actin in the nucleus goes along with the 
assembly of polymeric nuclear actin filaments, comparable to those in the cytoplasm, 
was in dispute (Pederson and Aebi, 2002). This was mainly due to the fact that nuclear 
actin structures were hardly detectable because of its general low nuclear abundance 
compared to its cytosolic fraction (Baarlink et al., 2013). Moreover, dynamic actin 
filaments could not be easily visualized in the nuclei of living somatic cells, as many 
actin detection methods such as genetically encoded fluorescently labeled actin or 
actin-binding proteins in general negatively influence functionality and kinetics (Belin 
et al., 2014; Spracklen et al., 2014).  
On the other hand, numerous actin-binding proteins, playing essential roles in 
cytoplasmic actin rearrangement, have been recently detected in the nucleus. Among 
the reported nuclear localized actin-binding proteins are for example the already 
before mentioned ARP2/3 complex (Yoo et al., 2007), its NPF N-WASP (Suetsugu and 
Takenawa, 2003; Wu et al., 2006) and myosins (de Lanerolle and Serebryannyy, 2011), 
as well as the p53-cofactor JMY (Shikama et al., 1999; Zuchero et al., 2012; Zuchero et 
al., 2009), profilin (Lederer et al., 2005; Söderberg et al., 2012) and the actin severing 
and disassembly regulators cofilin (Dopie et al., 2012; Obrdlik and Percipalle, 2011) or 
gelsolin (Archer et al., 2005).  
Furthermore, during apoptosis a caspase-3 mediated C-terminal FHOD1 cleavage 
product has been reported to translocate to the nucleus (Ménard et al., 2006). 
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Overexpression of this cleavage product resulted in RNA polymerase I inhibition in 
HeLa cells. All in all, the nuclear localization of proteins generally involved in assembly 
and disassembly of F-actin implies the presence of dynamic nuclear F-actin structures. 
Moreover, the human formin Diaphanous 1 (hDia1) was co-purified from HeLa cells in 
a complex with exportin 6 together with profilin-bound actin and other actin-binding 
proteins, thus suggesting nucleocytoplasmic shuttling of hDia1 (Stüven et al., 2003). 
Additionally, it was discovered that mDia2, but not mDia1 and mDia3, accumulates in 
the nucleus upon treatment with the CRM1-dependent nuclear export blocking drug 
Leptomycin B (LMB) (Miki et al., 2009). Functional analysis of the mDia2 amino acid 
sequence revealed at least one functional NLS and NES in this particular formin. Based 
on these studies it was suggested that mDia2 continuously shuttles between the 
nuclear and the cytoplasmic compartment using a specific transport machinery 
composed of importin-α/β and CRM1 (Miki et al., 2009).  
Worth mentioning, it is still under investigation if the activity-state of mDia affects its 
nuclear import. It has to be determined if there is a specialized nuclear mechanism of 
mDia activation or if formin activity is passively transduced towards the nucleus. 
Principally, mDia activation can occur prior to nuclear import in the cytoplasm or inside 
the nucleus upon entering the nuclear compartment. Generally, the majority of mDia 
resides in an autoinhibited state under unstimulated conditions. This suggests nuclear 
import of autoinhibited mDia, as CRM1 treatment leads to a rapid nuclear 
accumulation of mDia2 even without further stimulation. However, it remains unclear 
if mDia2 in its active open conformation is prevented from its nuclear import (Baarlink 
and Grosse, 2014; Plessner and Grosse, 2015). 
Recently, the first tools for detailed and reliable visualization of endogenous nuclear 
actin structures in living somatic cells became available (Baarlink et al., 2013; Belin et 
al., 2013; Melak et al., 2017; Plessner et al., 2015). For example, a role for polymerized 
nuclear actin in the context of integrin-based cellular adhesion and 
mechanotransduction through the LINC complex was described using a nuclear 
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targeted cameloid nanobody fused to TagGFP2, called nuclear Actin-Chromobody 
(Plessner et al., 2015).  
Although the occurrence of formins in the nucleus was reported previously (Miki et al., 
2009; Ménard et al., 2006; Stüven et al., 2003), their detailed functions remained 
unknown for years. However, quite recently, functions of formins in the assembly of 
nuclear F-actin were detected (Baarlink et al., 2013; Belin et al., 2015). For instance, a 
role for nuclear formin activity was suggested in DNA repair. It was shown that DNA 
damage leads to formation of nuclear actin filaments. Those filaments were assembled 
by nuclear localized Formin-2 together with the actin nucleators Spire-1 and Spire-2 
and promote clearance of double-strand DNA breaks (Belin et al., 2015).  
 
1.5.1 Formin regulated nuclear actin network formation and MRTF/SRF 
transcriptional activity  
Another recent study revealed nuclear mDia mediated signal induced regulation of 
actin filaments in the nucleus combined with alterations in MRTF-SRF transcriptional 
activity in mammalian cells (Baarlink et al., 2013). Using a nuclear targeted version of 
the actin probe LifeAct (Riedl et al., 2008), the dynamic assembly of a nuclear mDia 
dependent intranuclear actin network could be visualized upon stimulation with serum 
or LPA in living cells (Baarlink et al., 2013).  
The regulation of MRTF-A is a complex interplay between cytosolic and nuclear actin 
rearrangement. Binding of nuclear G-actin to MRTF-A promotes its export into the 
cytoplasm. In turn, an excessive amount of G-actin in the cytosol impairs its nuclear 
import (Figure 6). Therefore, MRTF-A activity was suggested to be dependent on the 
formation and disruption of G-actin-MRTF-A complexes in both compartments, 
indirectly mediated by polymerization-induced depletion of the overall G-actin pool 
(Mouilleron et al., 2011; Pawłowski et al., 2010; Vartiainen et al., 2007). Recent studies 
furthermore suggested that MRTF-A activation also requires active polymerization of 
nuclear F-actin, rather than just equilibration of the nuclear and cytoplasmic actin 
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pools. Additionally, mDia promoted nuclear F-actin formation appears to be sufficient 
to drive MRTF-A/SRF dependent gene expression, although it was suggested to be an 
integral part of a global cellular actin polymerization response that controls MRTF-
A/SRF activity (Baarlink et al., 2013).  
 
Figure 6: Nuclear F-actin formation by mDia regulates MRTF-A localization and activity 
Signaling mediated dynamic assembly and disassembly of nuclear actin filaments is directly linked to 
MRTF-A activity. MRTF-A continuously shuttles between the nucleus and the cytoplasm in an actin 
polymerization and depolymerization dependent manner. The binding of nuclear actin monomer to 
MRTF-A drives its nuclear export to the cytoplasm. In turn, binding of cytoplasmic G-actin inhibits access 
to the NLS of MRTF-A and thus impairs its nuclear import. Increased intranuclear F-actin formation, for 
example mediated by mDia, which actively shuttles between the cytoplasmic and the nuclear 
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compartment, depletes the amount of available nuclear G-actin for binding to MRTF-A and prevents 
MRTF-A from being exported from the nucleus. In the cytoplasm, assembly of F-actin promotes release 
of G-actin from MRTF-A and mediates MRTF-A shuttling to the nucleus. Subsequently, MRTF-A co-
activates SRF driven gene transcription. Upon nuclear F-actin disassembly, free G-actin binds again to 
MRTF-A and initiates its translocation to the cytoplasm, leading to inactivation of MRTF-A/SRF activity. 
Activation of nuclear mDia is sufficient to induce the assembly of nuclear F-actin structures and 
subsequent activation of MRTF-A/SRF activity. The image was adapted from (Baarlink and Grosse, 2014; 
Grosse and Vartiainen, 2013; Plessner and Grosse, 2015). 
 
1.6 The formin INF2 
Based on the results of previous publications it seems very likely that other formins, 
presumably members of the DRF family, might also perform a role in nuclear actin 
filament formation. One of the possible candidates to act in nuclear F-actin assembly 
was inverted formin 2 (INF2). Indeed, in a preliminary subcellular fractionation 
experiment, INF2 was also detected in the nucleus (H. Wang, unpublished data).  
The domain architecture of INF2 (Figure 7A) features multiple similarities with formins 
of the DRF subfamily. The mainly regulatory N-terminus contains a DID and a 
dimerization domain, whereas the C-terminus comprises an FH1, FH2 and a DAD. 
Interestingly, the DAD resembles a highly conserved monomeric actin binding WH2 
domain (Chhabra and Higgs, 2006).  
INF2 is capable of conducting two quite opposite functions regarding actin dynamics: 
besides promoting the formation and elongation of actin filaments, INF2 is also able to 
mediate actin filament severing and to accelerate depolymerization. The F-actin 
severing and depolymerization activity was shown to require ATP hydrolysis and 
subsequent phosphate release from the filament (Chhabra and Higgs, 2006). It was 
suggested that both, FH2 binding and phosphate release result in local F-actin 
deformation which in turn allows the DAD/WH2 domain to bind adjacent actin 
protomers followed by severing and depolymerization of the filament (Figure 7B) 
(Gurel et al., 2014). This combination of barbed end elongation, filament severing and 
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DAD/WH2 mediated depolymerization leads to formation of short and rather transient 
F-actin structures under nearby steady-state conditions. The activity of profilin thereby 
helps to overcome the rate-limiting step of nucleotide exchange (ADP-actin to ATP-
actin) upon release of G-actin from INF2, thus shifting the equilibrium toward 
polymerization and resulting in elongation of filaments (Gurel et al., 2015).  
 
Figure 7: INF2 mediated severing and depolymerization of actin filaments  
A) The cartoon illustrates the domain organization of INF2. B) A model for the INF2 mediated F-actin 
severing and depolymerization mechanism suggests that the partially dissociated INF2 dimer encircles 
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the filament either in a closed ring conformation or as an open dimer, arranged as a daisy chain. All 
severing and depolymerization steps in this model are displayed in the closed ring conformation, but 
could also be executed in an open dimer arrangement. Binding of the INF2 dimer leads to structural 
changes in the actin filament. Upon phosphate release, INF2 further deforms the filament close to its 
binding site, resulting in exposure of the DAD binding site of adjacent actin protomers. INF2-DAD/WH2 
subsequently keys in and destabilizes F-actin. This leads to severing of the filament with INF2 remaining 
bound to the newly formed barbed end (b). The DAD/WH2-bound ADP-actin subunits are released 
subsequently. The image was adapted from (Gurel et al., 2014). 
INF2 was shown to be autoinhibited by DID and DAD interaction. Remarkably, free 
actin monomers can compete with this interaction, thereby regulating actin 
polymerization as well as severing and depolymerization of actin filaments 
(Ramabhadran et al., 2013). Previous studies also implied binding of Cdc42 to INF2, 
thereby modulating its activity (Andrés-Delgado et al., 2010; Madrid et al., 2010). 
However, a direct interaction between INF2 and Cdc42 was rebutted and Cdc42 and 
INF2 were suggested to interact through additional proteins which serve as stabilizing 
factors for the DID and DAD interaction (Ramabhadran et al., 2013).  
Mammalian INF2 exists as two splice variants, differing in cellular localization and 
functions due to their distinct C-terminus: INF2 and INF2-CAAX (Chhabra et al., 2009; 
Ramabhadran et al., 2011). Generally, the C-terminal CAAX box is defined by a cysteine 
residue followed by two aliphatic residues (AA) and any amino acid depending on its 
localization or substrate specificity. CAAX proteins usually undergo a posttranslational 
prenylation process by either adding a farnesyl or a geranylgeranyl residue to the 
cysteine for anchoring the proteins to membranes (Gao et al., 2009).  INF2-CAAX is 
tightly bound to the endoplasmic reticulum (ER) (Chhabra et al., 2009) and modulates 
for example an actin dependent step during mitochondrial fission (Korobova et al., 
2013). INF2 lacking the CAAX box on the other hand mainly localizes to the cytoplasm 
and mediates for instance organization of the Golgi (Ramabhadran et al., 2011).  
A set of further INF2 functions has been described recently. In T-lymphocytes, INF2 
regulates the transport of the src-family kinase lymphocyte-specific protein tyrosine 
kinase (Lck) to the plasma membrane. Thereby, Cdc42 was proposed as factor to bind 
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and activate INF2 (Andrés-Delgado et al., 2010). Additionally, basolateral-to-apical 
transcytosis and lumen formation in hepatocytes was suggested to be Cdc42 and INF2 
dependent (Madrid et al., 2010). Furthermore, INF2 was linked to remodeling of the 
extracellular matrix in fibroblasts by promoting the formation of dorsal stress fibers 
and fibrillar focal adhesions (Skau et al., 2015). INF2 also modulates Ca2+-dependent 
mechanosensing by mediation of a rapid and transient perinuclear actin 
polymerization upon mechanical stimulation. This perinuclear actin remodeling is 
necessary for a rapid intracellular response to external force (Shao et al., 2015). Last 
but not least, INF2 has recently been identified as key regulator for a process termed 
Calcium-mediated Actin Reset (CaAR), which includes a rapid and transient actin 
rearrangement in response to increased intracellular calcium levels. CaAR affects 
processes such as cell spreading, wound healing, organelle immobilization and 
alterations in SRF-mediated gene transcription (Wales et al., 2016).  
Besides the direct regulation of actin polymerization and depolymerization, INF2 was 
also shown to antagonize Rho activated mDia signaling by heterodimeric interaction of 
INF2-DID and mDia-DAD (Sun et al., 2011). It has been demonstrated in cultured 
podocytes as well as in in vivo experiments that INF2 is an important modulator of 
Rho/mDia mediated actin dynamics, related to processes as lamellipodia formation 
and peripheral membrane trafficking (Sun et al., 2014; Sun et al., 2013). Additionally, a 
novel mechanism of serial formin activation was suggested, where mDia1 activates 
INF2 via interaction of mDia-DAD and INF2-DID and thereby regulates stable 
microtubules in migrating cells (Bartolini et al., 2016).  
Several missense mutations in INF2 have been associated to the occurrence of the 
demyelinating neuropathy Charcot–Marie–Tooth (CMT). CMT often comes along with 
the renal disease Focal and segmental glomerulosclerosis (FSGS), which frequently 
leads to overt kidney failure in adolescence or adulthood (Barua et al., 2013; Boyer et 
al., 2011; Brown et al., 2010; Gbadegesin et al., 2012). All so far identified INF2 
mutations are located in the DID. Some of these mutations, for instance E184K and 
R218Q, were described to inhibit the binding of INF2-DID to INF2-DAD and result in an 
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increased association with G-actin, the F-actin capping protein CapZ α-1 as well as 
profilin 2 (Rollason et al., 2016). Moreover, the mutations E184K and R218Q perturb 
the interaction of INF2-DID with mDia-DAD (Sun et al., 2011), leading to an impaired 
regulatory function of INF2 in terms of antagonizing Rho/mDia signaling (Sun et al., 
2014; Sun et al., 2013). Generally, the previous findings suggest that the emergence of 
FSGS and CMT is at least partially linked to aberrant fine regulation of actin dynamics. 
Furthermore, E184K and R218Q also prevent the formation of stabilized detyrosinated 
microtubules. Hence, mutated INF2 mediated lack of microtubule stability may also be 
disease relevant (Bartolini et al., 2016). However, the precise contribution of mutated 
INF2 to the etiology of FSGS and CMT is still unknown. 
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2. Aim of this study 
The appearance of monomeric actin in the nucleus of mammalian somatic cells, 
implicated in chromatin remodeling and the regulation of general eukaryotic gene 
transcription, was already widely accepted (de Lanerolle and Serebryannyy, 2011). In 
contrast, mainly due to limitations in detection, the existence of nuclear actin 
polymers remained elusive and was controversially discussed. Recently, specific 
nuclear actin probes have been described which enabled detailed visualization of F-
actin structures in the nuclei of fixed and living cells (Baarlink et al., 2013; Belin et al., 
2013; Melak et al., 2017; Plessner et al., 2015). Moreover, the discovery of several 
nuclear localized actin filament assembly proteins such as formins provided a first 
insight into regulation and function of actin polymerization in the nucleus (Baarlink et 
al., 2013; Belin et al., 2015).  
However, many details about nuclear F-actin assembly and the contributing actin 
nucleation factors as well as detailed insight into the potential roles of nuclear actin 
filaments are still unknown. Thus, further progress in elucidating the exact 
mechanisms on the formation of nuclear actin filaments and resulting cellular 
functions is highly demanded.  
The major aim of my thesis was to identify additional proteins which in terms of their 
intracellular localization and known actin-binding or actin-modulating properties are 
presumably involved in nuclear F-actin rearrangement. 
Overexpression of an isolated mDia-DAD in cells sterically interfered with the DID-DAD 
binding and resulted in a release of the autoinhibited state and activation of mDia. This 
was followed by F-actin assembly and subsequent increase in MRTF/SRF activity 
(Alberts, 2001; Baarlink et al., 2013). The initial question was if overexpression of an 
isolated DID is also capable to interfere with the DID-DAD binding to promote release 
of formin autoinhibition. Indeed, overexpression of different DIDs and the 
investigation of the capability to activate their corresponding formin revealed that 
mDia-DID and INF2-DID perform comparably in terms of formin activation and 
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induction of SRF activity. Moreover, activation of INF2 could also be obtained by 
overexpression of the isolated INF2-DAD. Thus, we generated a powerful tool to 
control autoinhibition of endogenous INF2, allowing us to analyze the cellular impact 
of regulated INF2 activity.  
Active mDia has been shown to mediate actin filament formation not only in the 
cytoplasm, but also inside the mammalian nucleus (Baarlink et al., 2013). Upon 
detection of endogenous INF2 in the nuclear extract by conducting subcellular 
fractionation experiments, we hypothesized that INF2 might also play a role in nuclear 
actin regulation. 
The following questions were addressed and investigated, mainly by the use of 
fluorescence confocal microscopy in fixed or living cells as well as by biochemical 
approaches: 
What are the nuclear import and export sequences enabling INF2 translocation to the 
nucleus and transport out of the nuclear compartment? 
Does nuclear targeted INF2 activation induce the formation of F-actin structures in the 
nucleus? 
Does nuclear INF2 activity affect subcellular localization of MRTF-A and subsequent 
MRTF/SRF transcriptional regulation? 
Are the effects upon activation of INF2 by overexpression of its DAD specific for INF2 
or due to involvement of other proteins, such as mDia formins? 
Taken together, this study should extend our knowledge of factors involved in actin 
polymerization in the somatic cell nucleus.  
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3. Materials and Methods 
3.1 Materials 
Table 2: Reagents used in this study 
Name Supplier 
2-Mercaptoethanol Sigma-Aldrich 
Acetic Acid Roth 
Agarose NEEO Ultra Roth 
Ammonium persulfate (APS) Merck 
Ampicillin Roth 
BES Sigma 
Bovine serum albumin (BSA) Roth 
Bromophenol blue Roth 
Calcium chloride (CaCl2) Roth 
Chloroform Roth 
Coomassie brilliant blue G250 Roth 
DAPI Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) Roth 
Dithiothreitol (DTT) Roth 
DMEM (HPSTA) Capricorn Scientific 
DNA ladder 1kb plus Thermo Fisher Scientific 
DNA loading dye 6x Thermo Fisher Scientific 
dNTPs Promega 
EGTA Sigma-Aldrich 
Enzymes for cloning Thermo Fisher Scientific 
Ethanol Roth 
Ethidium bromide Roth 
Ethylendiamintetraacetat (EDTA) Roth 
Fetal calf serum (FCS) Thermo Fisher Scientific 
FLAG (M2) conjugated agarose beads Sigma-Aldrich 
Fluorescent mounting medium DAKO 
Formaldehyde solution 37% Roth 
Fugene HD Promega 
GeneRuler 1kb plus DNA ladder Thermo Fisher Scientific 
Glucose Roth 
Glutaraldehyde Sigma-Aldrich 
Glycerol Roth 
H2O2 Sigma-Aldrich 
HEPES Roth 
iQ SYBR-Green® Supermix Bio-Rad 
Isopropanol Roth 
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Kanamycin Roth 
Lipofectamine LTX/Plus Thermo Fisher Scientific 
Lipofectamine RNAiMAX Thermo Fisher Scientific 
Magnesium chloride (MgCl2) Roth 
Methanol Roth 
Milk powder (fat free) Roth 
Myc conjugated agarose beads Sigma-Aldrich 
NP-40 Merck 
OptiMEM Thermo Fisher Scientific 
PageRuler Plus Prestained Protein Ladder Thermo Fisher Scientific 
Paraformaldehyde Roth 
Passive lysis buffer 5x Promega 
PCR primer Sigma-Aldrich 
Penicillin Streptomycin PAA 
Phalloidine (conjugated) Thermo Fisher Scientific 
Phosphate-buffered saline (PBS) PAA 
Phusion Hot Start II High-Fidelity DNA Polymerase Thermo Fisher Scientific 
Ponceau S solution Sigma-Aldrich 
Potassium chloride (KCl) Roth 
Protease inhibitor cocktail (COMPLETE) Roche 
Random hexamers Thermo Fisher Scientific 
RevertAid Reverse Transcriptase Thermo Fisher Scientific 
RiboLock RNase Inhibitor Thermo Fisher Scientific 
RotiPhorese® Gel 30 (Acrylamide-Bisacrylamide solution) Roth 
Saponine Sigma-Aldrich 
siRNA FlexiTube QIAGEN 
Sodium azide Sigma-Aldrich 
Sodium borohydride (NaBH4) Sigma-Aldrich 
Sodium chloride (NaCl) Roth 
Sodium deoxycholate Sigma-Aldrich 
Sodium dihydrogenphosphate (Na2H2PO4 .H2O) Roth 
Sodium dodecyl sulphate (SDS) Roth 
Sodium hydroxide (NaOH) Sigma-Aldrich 
T4 DNA ligase Thermo Fisher Scientific 
Tetramethylethylenediamine (TEMED) Roth 
TRIS Roth 
Triton X-100 (TX-100) Sigma-Aldrich 
TRIzol® Thermo Fisher Scientific 
Trypsin-EDTA 0.05% Capricorn Scientific 
Tryptone Roth 
Tween-20 Roth 
Yeast extract Roth 
2-(N-Morpholino)ethansulfonsäure (MES) Sigma 
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Table 3: Standard solutions, buffers and bacterial growth medium 
Solution Composition 
BES-buffered saline (BBS) 2x BES   50 mM 
NaCl   280 mM 
Na2HPO4  1.5 mM 
pH 6.95 
Blocking buffer for immunoblotting Milk powder  5% (w/v) 
in TBST 
Coomassie destaining solution Acetic acid  10% (v/v) 
Methanol  20% (v/v) 
Coomassie staining solution Coomassie G250 0.1% (w/v) 
Acetic acid  10% (v/v) 
Methanol  40% (v/v) 
Cytoskeleton buffer MES   10 mM  
NaCL   150 mM  
EGTA   5 mM  
Glucose  5 mM  
MgCl2   5 mM  
pH 6.1 
Laemmli buffer 4x Glycerol     28% (v/v) 
EDTA      10 mM  
SDS       5.7% (v/v) 
2-mercaptoethanol   4.7 mg/ml 
Bromophenol blue   3.5 mg/ml 
Tris-HCl     286 mM 
pH 6.8 
LB agar NaCl   1% (w/v) 
Yeast extract  0.5% (w/v) 
Tryptone  1% (w/v) 
Agar   1.5% (w/v) 
LB medium NaCl       1% (w/v) 
Yeast extract    0.5% (w/v) 
Tryptone     1% (w/v) 
PBS Na2HPO4     8 mM  
KH2PO4     1.5 mM  
NaCl       137 mM  
KCl       2.7 mM 
pH 7.4 
PBST Tween 20  1% (w/v) 
in PBS 
Ponceau S staining solution Ponceau S solution 0.5% (v/v) 
Acetic acid  3% (v/v) 
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RIPA buffer Tris-HCl  50 mM 
NaCl   150 mM 
NP-40   1% (v/v) 
EDTA   2 mM 
SDS   0.1% (w/v) 
Na-Deoxycholate 0.5% (w/v) 
pH 8.0 
SDS-PAGE running buffer 1x Glycine     192 mM  
SDS       0.1% (w/v) 
Tris-HCl     25 mM 
pH 8.3 
SDS-PAGE separating gel RotiPhorese® Gel 30 8–15% 
(v/v) 
TEMED     9.5 µM  
SDS       0.1% (w/v) 
Tris-HCl     0.36 M  
APS      0.1% (w/v) 
pH 8.8 
SDS-PAGE stacking gel RotiPhorese® Gel 30 19% (v/v) 
TEMED     14.5 µM  
SDS       0.1% (w/v) 
Tris-HCl     0.12 M  
APS   0.15% 
(w/v) 
pH 6.8 
Subcellular fractionation – cell lysis buffer HEPES   10 mM 
KCl   10 mM 
EGTA   0.1 mM 
DTT   1 mM 
NP-40   0.5% (v/v) 
COMPLETE  1:20 
pH 7.9 
Subcellular fractionation – nuclear extraction 
buffer 
HEPES   20 mM 
NaCl   400 mM 
EDTA   1 mM 
DTT   1 mM 
COMPLETE   1:20 
pH 7.5 
TBST buffer NaCl    500 mM 
Tris-HCl   20 mM 
Tween-20   1% (v/v) 
pH 7.5 
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Transfer buffer for immunoblotting Glycine     192 mM  
Tris-HCl     25 mM  
Methanol     20% (v/v) 
pH 8.5  
Tris-Acetat-EDTA (TAE) buffer EDTA      2 mM  
Tris-HCl  40 mM 
Acetic acid     20 mM 
pH 8.0 
 
Table 4: Antibodies and fluorescent dyes used in this work 
Antibody Supplier Dilution (in blocking 
buffer) 
Alexa Fluor conjugated 2nd AB Thermo Fisher Scientific IF 1:400 
SNAP-Cell 647 SiR New England BioLabs IF 1:200 
α-c-Myc, TRITC conjugated Santa Cruz IF 1:200 
α-FLAG, HRP conjugated Sigma-Aldrich WB 1:3000 
α-GFP Santa Cruz IF 1:400 
α-HDAC2 Abcam WB 1:5000 
α-INF2 Proteintech WB 1:1000, IF 1:100 
α-Lamin A/C Cell Signaling IF 1:100 
α-mDia1 BD WB 1:1000, IF 1:100 
α-mDia2 M. Innocenti Lab, NL WB 1:1000 
α-Mouse IgG, HRP conjugated GE Healthcare WB 1:5000 
α-Myc, HRP conjugated Sigma-Aldrich WB 1:2500 
α-Rabbit IgG, HRP conjugated Bio-Rad WB 1:5000 
α-Tubulin Cell Signaling WB 1:5000 
α−H3K4Me1 Abcam IF 1:200 
α-β Actin Sigma-Aldrich WB 1:3000 
 
Table 5: Biochemical Kits used in this work 
Name Supplier 
Dual-Luciferase® Reporter Assay System Promega 
NucleoSpin® gel and PCR clean-up Marcherey-Nagel 
NucleoSpin® Plasmid Marcherey-Nagel 
Pierce® ECL Western Blotting Substrate Thermo Fisher Scientific 
PureLinkTM HiPure Plasmid Filter Maxiprep Kit Thermo Fisher Scientific 
 
Table 6: Special equipment, devices and working materials used in this study 
Name Supplier 
Blue LED illumination device In-house made 
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Centrifuge 5415R Eppendorf 
Forma Series II 3110 Water-Jacketed CO2 Incubators Thermo Fisher Scientific 
Glass bottom dishes 3.5 cm MatTek 
LSM 700 confocal microscope, 63x, 1.4 NA oil objective Zeiss 
LuminoskanTM Ascent Microplate Luminometer Thermo Fisher Scientific 
Mini-Trans-Blot System Bio-Rad 
NanoDrop 1000 Peqlab 
Nikon Eclipse Ti microscope Nikon 
PowerPack 300 Bio-Rad 
Protran Nitrocellulose Transfermembran 0.45 µm Whatman 
INFINITY gel documentation Peqlab 
T3 Thermocycler Biometra 
Thermomixer compact Eppendorf 
X-Ray film processor Medical Index GmbH 
X-Ray films Kodak 
 
Table 7: Software used for this study 
Name Supplier 
AscentTM Software Thermo Fisher Scientific 
Illustrator CS5 Adobe 
ImageJ / Fiji Open Source 
MS Office 2010 Microsoft 
Photoshop CS5 Adobe 
Prism 6 Graph Pad Software 
Serial Cloner 2.6.1 Serial Basics 
Zen 2009 light edition Zeiss 
Zen 2012  Zeiss 
Imaris 8.3.1 Bitplane 
 
 
3.2 Cell Culture 
3.2.1 General cell culture 
HEK293, NIH3T3, HeLa, HT29 and LOX cells were maintained in DMEM (HPSTA – high 
glucose, stable glutamine and sodium pyruvate, Capricorn Scientific) supplemented 
with 10% fetal bovine serum (FCS) under standard conditions at 37°C in a 5% CO2 
environment.  
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Table 8: Cell lines used in this study 
Name Type 
HEK293 Human embryonic kidney cells 
HeLa Human cervical carcinoma cells 
HT29 human colorectal adenocarcinoma cells 
LOX Human melanoma cells 
NIH3T3 Mouse embryonic fibroblast cells 
 
3.2.2 Transfection of DNA 
In HEK293 cells, plasmids were transfected using the calcium phosphate method. 
Briefly, cells were pre-seeded in cell culture dishes 24 h before transfection. For a 3.5 
cm dish, the DNA was diluted and mixed in 112.5 µl ultrapure bidest H2O. 125 µl 2x 
BBS was added after mixing, followed by 12.5 µl CaCl2. After gentle vortexting, the 
transfection mixture was incubated for 15 min at RT before adding it dropwise to the 
subconfluent cells. After around three hours upon transfection, the transfection 
medium was replaced with fresh 10% DMEM and cells were incubated overnight (o/n) 
at 37°C in a 5% CO2 environment before further application. 
HeLa cells were transfected using Fugene HD (Promega) according to the 
manufacturer’s instructions. The DNA was mixed in 100 µl serum free DMEM or 100 µl 
OptiMEM. 4 µL of Fugene HD was added and mixed. After 15 min of incubation at RT, 
the transfection mixture was added dropwise to the subconfluent cells, which were 
seeded in a 3.5 cm tissue culture dish the day before. Cells were incubated o/n at 37°C, 
5% CO2 before carrying out further experiments.  
The other cell lines used in this study (NIH3T3, LOX and HT29) were transfected using 
Lipofectamine LTX/Plus (Thermo Fisher Scientific) according to the manufacturer’s 
protocol. The plasmids were mixed in 100 µl serum free DMEM or 100 µl OptiMEM 
and 2 µl Plus-reagent was added. Upon mixing, the solution was incubated for 5 min at 
RT. Subsequently, 4 µL LTX-reagent were added. The transfection mixture was then 
incubated for further 15 min and added to subconfluent pre-seeded cells in a 3.5 cm 
cell culture dish. Before carrying out further experiments, cells were incubated o/n 
(37°C, 5% CO2).  
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3.2.3 Transfection of siRNA 
All siRNAs were purchased from Qiagen. The targeting sequences of siRNAs used in this 
work are indicated in table 9. siRNAs were transfected using Lipofectamine RNAiMAX 
(Thermo Fisher Scientific) following the manufacturer’s instructions. For siRNA 
treatment of cells seeded in a 3.5 cm cell culture dish, 5 µL of the transfection reagent 
were diluted and mixed in 250 µL OptiMEM. In a separate tube, 2.5 µl siRNA of a 20 
µM siRNA solution, corresponding to a final concentration of 10 nM, were diluted and 
mixed with 250 µL OptiMEM. Both solutions were then mixed together and incubated 
for 20 min at RT. Afterwards, the transfection mix was added to the subconfluent cells 
and incubated for 48 h at 37°C in a 5% CO2 environment before further application. If 
it was necessary, cells were split 24 h after siRNA transfection.  
Table 9: siRNA targeting sequences (FlexiTube siRNA, QIAGEN) 
Name Sequence 5’ to 3’ 
Mm_2610204M08Rik_1 (siINF2 #1) CCGGAAGGAACAGATGGCAAA 
Mm_2610204M08Rik_2 (siINF2 #2) CTGGCAGAAGCTGCCATCCAA 
Mm_2610204M08Rik_3 (siINF2 #3) AAGCATGAGATTGAGAACCTA 
Mm_2610204M08Rik_4 (siINF2 #4) TAGGCTCTAGGGAACAAATAA 
Mm_mDia1 #1_5 CAGGAACAGTATAACAAACTA 
Mm_mDia2 #3_2 AAGGAGCTTAATTATAAATCTA 
 
3.2.4 Photoactivation of LOV-INF2-DAD 
Optogenetic activation of LOV-INF2-DAD derivatives was obtained by the incubation of 
cells at 37°C in a 5% CO2 atmosphere under constant illumination by blue LED for 3 
hours. Upon illumination, cells were analyzed with a LSM 700 confocal microscope 
(Zeiss), equipped with a 63X, 1.4 NA oil objective and the ZEN 2012 software (Zeiss).  
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3.3 Molecular biological methods 
3.3.1 DNA cloning and constructs 
Expression vectors were generated by using standard cloning procedures. DNA 
fragments were obtained by PCR reactions using Phusion Hot Start II High-Fidelity DNA 
Polymerase in HF or CG buffer (Thermo Fisher Scientific) according to the 
manufacturer’s instructions. Additionally, the PCR reaction contained 100 ng DNA 
template, 100 nM of each primer (forward and reverse), 2 – 3 µl DMSO (optional), and 
was filled with bidest H2O to a total volume of 50 µl. The primers used in this study are 
summarized in Table 11. The DNA template was either cDNA from pre-existing 
plasmids or cDNA obtained by reverse transcription from the total mRNA amount of 
cells derived from mouse or human. The PCR reaction was conducted using a T3 
Thermocycler (Biometra) with the following conditions: 
denaturation 98°C 30 sec    
  
denaturation 98°C 10 sec 
annealing X°C 30 sec X: 55°C – 72°C 30 cycles total 
extension 72°C X sec X: 30 sec – 3 min   
  
final extension 72°C 5 min 
storage 4°C 
The PCR products were separated on an agarose gel containing ethidium bromide and 
were visualized under UV light. The DNA fragment was then extracted from the 
agarose gel and digested together with the respective cloning vector using appropriate 
DNA restriction endonucleases. The respective restriction sites of the generated 
constructs can be seen in Table 11. All restriction enzymes were purchased from 
Thermo Fisher Scientific and the DNA digestion reactions were conducted according to 
the manufacturer’s instructions. Upon digestion, the DNA was separated again on an 
agarose gel and extracted. Afterwards, the digested vector backbone and the DNA 
insert were combined at a ratio of around 1:3 or 1:4 and ligated using T4 ligase 
(Thermo Fisher Scientific) in accordance to the manufacturer’s protocol. 6 µl of the 
ligation reaction were transformed into DH5α bacterial cells. Cells were then plated on 
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LB agar (containing either ampicillin or kanamycin) and incubated at 37°C o/n. Grown 
bacterial colonies were picked and incubated o/n in 3 ml liquid antibiotics containing 
LB medium. Plasmids were then extracted from bacterial cells by using the 
NucleoSpin® Plasmid Miniprep Kit (Marcherey-Nagel). The extracted plasmids were 
finally sent for DNA sequencing, conducted by Macrogen, Amsterdam, NLD.  
Plasmids were expressed under the control of the EF-1α promotor as derivatives of 
pEF-pLink2 carrying N-terminal FLAG, FLAG- GFP, MYC, MYC-mCherry or MYC-TagBFP2 
epitope tags.  hINF2-DID (aa 32-266), hINF2-DAD-core (aa 941-1015) and hINF2-DAD 
(aa 965-1240) were amplified from human cDNA, based on the sequence of human 
INF2 (NCBI Reference Sequence: NP_001026884.3). hINF2-DAD-CAAX (aa 965-1249) 
was based on the human cDNA sequence of human INF2-CAAX (NP_071934.3). mINF2-
DID (aa 32-267) was based on mouse INF2 (NP_940803.2). Other DID constructs 
comprise the following amino acids according to their respective mouse or human 
cDNA sequence: mDia1-DID (aa 129-369), mDia2-DID (aa 149-397), mDia3-DID (aa 163 
– 399), hFMNL2-DID (aa 75-399), hFMNL2-DID (aa 71-391), hFMNL3-DID (aa 74-395), 
hFHOD1-DID (aa 115-341), hFHOD3-DID (aa 103-332). The SV40 large T antigen NLS 
(PPKKKRKV) was C-terminally fused with one linking glycine to restrict constructs to the 
nucleus. To enable nuclear export, known NES sequences of HIV-Rev (LPPLERLTL) and 
Stat3 (SLAAEFRHLQLK) were used. GFP-INF2 and GFP-INF2-CAAX (both in pEGFP-C1 
vector backbone) were a gift from the Higgs-Lab. GFP-INF2-A149D and GFP-INF2-
A149D-CAAX were generated by site-directed mutagenesis with a subsequent Dpn1 
digestion step (2h at 37°C).  
Table 10: Expression vectors and pre-existing constructs used in this study 
Name Comments 
Actin-Chromobody-GFP-NLS cloned by C. Baarlink, R. Grosse Lab, Marburg, D 
Actin-Chromobody-SNAP cloned by C. Baarlink, R. Grosse Lab, Marburg, D 
Lamin-Chromobody-SNAP cloned by C. Baarlink, R. Grosse Lab, Marburg, D 
pEF-FLAG-mDia2-DAD-L1168G-
NLS 
cloned by C. Baarlink, R. Grosse Lab, Marburg, D 
pAC-TagGFP Chromotek 
pLC-TagRFP Chromotek 
pEGFP-C1 Clontech 
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pEGFP-C1-hINF2 Gift from H. Higgs Lab, Hanover, USA 
pEGFP-C1-hINF2-CAAX Gift from H. Higgs Lab, Hanover, USA 
LifeAct-GFP Gift from M. Sixt Lab, Klosterneuburg, AUT 
pRL-TK Promega 
MRTF-A-GFP R. Treisman Lab, London, UK 
pEF-pLINK2 R. Treisman Lab, London, UK 
pGL3D.AFOS R. Treisman Lab, London, UK 
 
Table 11: Primers for cloning used in this study 
Oligo name Sequence 5’ to 3’ 
mDia1DID fw GCGCGCGCATGGACGAGCTGTACAAGGGCCAGAAAGAGAGC
TCTAGGTCTGC 
mDia2DID fw GCGCGCGCATGGACGAGCTGTACAAGGGCAGTAGCCGACAG
ATCTCACCTC 
mDia1DID NLS SpeI rev GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGGCCT
CCCTTCAGATCAAAGAAATC 
mDia2DID NLS SpeI rev GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGGCCA
GATGCTTCATCAAGTTCAGC 
mDia1DID NLS SpeI rev GCGCGCACTAGTCTATCCCTTCAGATCAAAGAAATC 
mDia2DID NLS SpeI rev GCGCGCACTAGTCTAAGATGCTTCATCAAGTTCAGC 
EcoRI mCherry fw GCGCGCGAATTCATGGTGAGCAAGGGCGAGGAGG 
FHOD1 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGCTCTCCGTGA
GGGTCAATGC 
FHOD1 m rev DID GCGCGCACTAGTCTAAGCCTCTTCCATATCTCCATC 
FHOD1 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGCTCTCTGTGA
GGGTCAACG 
FHOD1 h rev DID GCGCGCACTAGTCTAGATGTCTCCATCCTCCAATTTCAG 
FHOD3 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGCTGTCTGTG
AGGGTCCATG 
FHOD3 m rev DID GCGCGCACTAGTCTACTCAGCTGTCTCATCACCATC 
FHOD3 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGCTGTCTGTG
AGGGTCCATG 
FHOD3 h rev DID GCGCGCACTAGTCTACTCCGTGGTCTCATCGCCATC 
FMNL1 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAAGTCAAGAAT
CCCCCTGC 
FMNL1 m rev DID GCGCGCACTAGTCTACAACACTGCATTCTTCGTCTC 
FMNL1 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAAGTCAAGAAT
CCCCCCGCAG 
FMNL1 h rev DID GCGCGCACTAGTCTACAGCACAGCGTTCTTGGTCTC 
FMNL2 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGGTGAAGAAC
CCTCCCCATAC 
FMNL2 m rev DID GCGCGCACTAGTCTACAAGGCAGCATTCTTGGTTTCTG 
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FMNL2 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGGTGAAGAAT
CCTCCCCATAC 
FMNL2 h rev DID GCGCGCACTAGTCTACAAGGCAGCATTCTTAGTTTCAG 
FMNL3 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAAGTAAAGAAT
CCTCCCCACAC 
FMNL3 m rev DID GCGCGCACTAGTCTACAGGGCTACATTCTTGGTTTCTG 
FMNL3 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCCAGGTGAAGAAT
CCTCCCCAC 
FMNL3 h rev DID GCGCGCACTAGTCTACAGGGCTACATTCTTGGTCTC 
INF2 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCAGCGCCGAGCCT
GAGCTGTGC 
INF2 m rev DID GCGCGCACTAGTCTACCCATCGCTAATTCGCTGAAG 
INF2 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCAGCGCGGACCCC
GAGCTGTGC 
INF2 h rev DID GCGCGCACTAGTCTAGACCCCGCCAGAGACTCGCAG 
mDia3 m fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCACCCTTTCTTCAC
AAGAATATG 
mDia3 m rev DID GCGCGCACTAGTCTAATTGAGACGGTGGGATAATTCAC 
Diaph2 h fw DID GCGCGCGCATGGACGAGCTGTACAAGGGCACCCTGTCTTCAC
AAGAATATG 
Diaph2 h rev DID GCGCGCACTAGTCTAATTGAGACGGTGTGATAATTCAG 
BamH1 mCherry fw  GCGCGCGGATCCATGGTGAGCAAGGGCGAGGAGG 
TagBFP2 EcoRI fw GCGCGCAGGAATTCGATGAGCGAGCTGATTAAGGAGAAC 
TagBFP2 XbaI rev GCGCGCTCTAGACTAATTAAGCTTGTGCCCCAGTTTGC 
mCh INF2 DAD short f GCGCGCGCATGGACGAGCTGTACAAGGGCGGGAAGCAGGA
GGAGGTGTG 
hINF2DAD short SpeI r GCGCGCACTAGTCTAGCTGCCCCCGTCGGTGTCC 
hINF2DAD short NLS 
SpeI r 
GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGCCCG
CTGCCCCCGTCGGTGTCC 
INF2 m rev BcuI NLSDID GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGCCCC
CCATCGCTAATTCGCTGAAG 
INF2 h rev BcuI NLSDID GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGCCCG
ACCCCGCCAGAGACTCGCAG 
hINF2 DAD fw GCGCGCGCATGGACGAGCTGTACAAGGGCAAGCAGCAGCTG
GCGGAGGAGG 
hINF2 DAD BcuI rev GCGCGCACTAGTCTACACAGGCTCTGTGGCTCTTGG 
hINF2 DAD BcuI NLS rev GCGCGCACTAGTCTACACCTTCCGCTTTTTCTTAGGCGGCCCC
ACAGGCTCTGTGGCTCTTGG 
MluI BFP PWPXL fw GCGCGCACGCGTCCTAGCGCTACCGGTCGCCACCATGGTGTC
TAAGGGCGAAGAGCTGATTAAGGAGAACATGCAC 
EcoRI BFP PWPXL rev GCGCGCGAATTCCTATCGAGATCTGAGTCCGGAATTAAGCTT
GTGCCCCAGTTTGC 
PmeI MAL fw GCGCGCGTTTAAACTAATGCTGCCCCCTTCCGTCATTGCTG 
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3xRPEL BFP fw GCGCGCGTAAATTACCCAAAGGTAGCAGACAGTGGGATGGT
GTCTAAGGGCGAAGAGCTG 
BFP MluI rev GCGCGCACGCGTATTAAGCTTGTGCCCCAGTTTGC 
hINF2 EcoRI f GCGCGCGAATTCATGTCGGTGAAGGAGGGCGCAC 
LOV hINF2DAD 1 GCAGAAGAGATTGATGAGGCGGCAGGAGAGGACGGGAAGC
CTGTCAG 
LOV hINF2DAD 2 GCAGAAGAGATTGATGAGGCGGCAGAGGACGGGAAGCCTGT
CAGGAAG 
LOV hINF2DAD 3 GCAGAAGAGATTGATGAGGCGGCAGACGGGAAGCCTGTCAG
GAAG 
LOV hINF2DAD 4 GCAGAAGAGATTGATGAGGCGGCAGGGAAGCCTGTCAGGAA
GG 
LOV hINF2DAD 5 GCAGAAGAGATTGATGAGGCGGCAAAGGGGCCCGGGAAGC
AGGAG 
LOV hINF2DAD 6 GCAGAAGAGATTGATGAGGCGGCAGGGCCCGGGAAGCAGG
AGGAG 
LOV hINF2DAD 7 GCAGAAGAGATTGATGAGGCGGCACCCGGGAAGCAGGAGG
AGGTG 
LOV hINF2DAD 8 GCAGAAGAGATTGATGAGGCGGCAGGGAAGCAGGAGGAGG
TGTGTG 
LOV hINF2DAD 9 GCAGAAGAGATTGATGAGGCGGCAAAGCAGGAGGAGGTGT
GTGTCATC 
LOV hINF2DAD 10 GCAGAAGAGATTGATGAGGCGGCACAGGAGGAGGTGTGTGT
CATC 
LOV hINF2DAD 11 GCAGAAGAGATTGATGAGGCGGCAGAGGAGGTGTGTGTCAT
CGATG 
LOV hINF2DAD 12 GCAGAAGAGATTGATGAGGCGGCAGAGGTGTGTGTCATCGA
TGC 
LOV hINF2DAD 13 GCAGAAGAGATTGATGAGGCGGCAGTGTGTGTCATCGATGC
CCTGCTG 
LOV hINF2DAD 14 GCAGAAGAGATTGATGAGGCGGCATGTGTCATCGATGCCCTG
CTG 
LOV hINF2DAD 15 GCAGAAGAGATTGATGAGGCGGCAGTCATCGATGCCCTGCTG
GCTG 
LOV hINF2DAD I539E 1 GCAGAAGAGGAAGATGAGGCGGCAGGAGAGGACGGGAAGC
CTGTCAG 
LOV hINF2DAD I539E 2 GCAGAAGAGGAAGATGAGGCGGCAGAGGACGGGAAGCCTG
TCAGGAAG 
LOV hINF2DAD I539E 3 GCAGAAGAGGAAGATGAGGCGGCAGACGGGAAGCCTGTCA
GGAAG 
LOV hINF2DAD I539E 4 GCAGAAGAGGAAGATGAGGCGGCAGGGAAGCCTGTCAGGA
AGG 
LOV hINF2DAD I539E 5 GCAGAAGAGGAAGATGAGGCGGCAAAGGGGCCCGGGAAGC
AGGAG 
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LOV hINF2DAD I539E 6 GCAGAAGAGGAAGATGAGGCGGCAGGGCCCGGGAAGCAGG
AGGAG 
LOV hINF2DAD I539E 7 GCAGAAGAGGAAGATGAGGCGGCACCCGGGAAGCAGGAGG
AGGTG 
LOV hINF2DAD I539E 8 GCAGAAGAGGAAGATGAGGCGGCAGGGAAGCAGGAGGAG
GTGTGTG 
LOV hINF2DAD I539E 9 GCAGAAGAGGAAGATGAGGCGGCAAAGCAGGAGGAGGTGT
GTGTCATC 
LOV hINF2DAD I539E 
10 
GCAGAAGAGGAAGATGAGGCGGCACAGGAGGAGGTGTGTG
TCATC 
LOV hINF2DAD I539E 
11 
GCAGAAGAGGAAGATGAGGCGGCAGAGGAGGTGTGTGTCA
TCGATG 
LOV hINF2DAD I539E 
12 
GCAGAAGAGGAAGATGAGGCGGCAGAGGTGTGTGTCATCGA
TGC 
LOV hINF2DAD I539E 
13 
GCAGAAGAGGAAGATGAGGCGGCAGTGTGTGTCATCGATGC
CCTGCTG 
LOV hINF2DAD I539E 
14 
GCAGAAGAGGAAGATGAGGCGGCATGTGTCATCGATGCCCT
GCTG 
LOV hINF2DAD I539E 
15 
GCAGAAGAGGAAGATGAGGCGGCAGTCATCGATGCCCTGCT
GGCTG 
EcoRI LOV fw GCGCGCGAATTCGGCTTGGCTACTACACTTGAACG 
mCh LOV fw GCGCGCGCATGGACGAGCTGTACAAGGGCTTGGCTACTACAC
TTGAACG 
EcoRI mDia1DID fw GCGCGCGAATTCATGCAGAAAGAGAGCTCTAGGTCTGC 
EcoRI mDia2 DID fw GCGCGCGAATTCATGAGTAGCCGACAGATCTCACCTC 
EcoRI hINF2 DAD fw GCGCGCGAATTCATGAAGCAGCAGCTGGCGGAGGAGG 
EcoRI hINF2 DADWH2 GCGCGCGAATTCATGGGGAAGCAGGAGGAGGTGTG 
EcoRI hINF2 DID GCGCGCGAATTCATGAGCGCGGACCCCGAGCTGTGC 
BamHI mINF2 DID GCGCGCGGATCCATGAGCGCCGAGCCTGAGCTGTGC 
hINF2 DAD 3xLtoA GAGGTGTGTGTCATCGATGCCGCTGCTGCTGACATCAGGAAG
GGCTTCCAGGCTCGGAAGACAGCCCGGGGCCGCGGGGAC 
hINF2 DID A149D GAAGCAGGTGTTTGAGCTACTGGCTGACCTGTGCATCTACTCT
CCCGAGGGCCAC 
hINF2 FH2 I643A CAAGAAGAGCCTGAACCTCAACGCATTCCTGAAGCAATTTAA
GTGCTCCAACGAG 
hINF2 FH2 K792A GATCAGCACATTGCTGAAGCTCACGGAGACCGCATCCCAGCA
GAACCGCGTGACGCTGCTGCAC 
hINF2 +CAAX SpeI rev GCGCGCACTAGTCTATCACTTGGCCTTGGGCCTGGGCCTGTTT
GTTTTATTATCATC 
hINF2 –CAAX SpeI rev GCGCGCACTAGTCTATCACTTGGCCTTGGGCCTGGGCCTG 
hINF2 DID E184K fw CTTCAGCATTGTCATGAACAAGCTCTCCGGCAGCGACAAC 
hINF2 DID E184K rev GTTGTCGCTGCCGGAGAGCTTGTTCATGACAATGCTGAAG 
hINF2 DID R218Q fw CTGCGCGCGCGCACCCAGCTGCAAAACGAGTTTATCGGGCTG 
hINF2 DID R218Q rev CAGCCCGATAAACTCGTTTTGCAGCTGGGTGCGCGCGCGCAG 
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I2 A149D SDM fw GTGTTTGAGCTACTGGCTGACCTGTGCATCTACTCTCC 
I2 A149D SDM rev GGAGAGTAGATGCACAGGTCAGCCAGTAGCTCAAACAC 
EcoRI BFP fw GCGCGCGAATTCATGGTGTCTAAGGGCGAAGAGCTG 
BFP LOV fw GCGCGCGCAAACTGGGGCACAAGCTTAATGGCTTGGCTACTA
CACTTGAACG 
LOV GS hI2DAD 969 GCAGAAGAGATTGATGAGGCGGCAGGCGGTAGCGGAGGTTC
TGAGGTGTGTGTCATCGATGC 
LOV GS hI2DAD 970 GCAGAAGAGATTGATGAGGCGGCAGGCGGTAGCGGAGGTTC
TGTGTGTGTCATCGATGCCCTGCTG 
LOV GS hI2DAD 971 GCAGAAGAGATTGATGAGGCGGCAGGCGGTAGCGGAGGTTC
TTGTGTCATCGATGCCCTGCTG 
LOV GSGS hI2DAD 971 GCAGAAGAGATTGATGAGGCGGCAGGCAGCGGATCTTGTGT
CATCGATGCCCTGCTG 
LOV GS hI2DAD 971 GCAGAAGAGATTGATGAGGCGGCAGGTTCTTGTGTCATCGAT
GCCCTGCTG 
LOV GGS hI2DAD 971 GCAGAAGAGATTGATGAGGCGGCAGGCGGTAGCTGTGTCAT
CGATGCCCTGCTG 
hINF2 NLS1 fw GCGCGCGAATTCCGGGCCAGGAAGGAGCCCAAG 
hINF2 NLS1 rev GCGCGCACTAGTCTAGCACTTAAATTGCTTCAGGAAG 
hINF2 NLS2 fw GCGCGCGAATTCTTCAGCACCATGAAGGCTTTC 
hINF2 NLS2 rev GCGCGCACTAGTCTACTTCCTCCTCTCTGCCTTCG 
hINF2 NLS3 fw GCGCGCGAATTCCGGGCCTCAAAGGGGACCGGGAAG 
hINF2 NLS3 rev GCGCGCACTAGTCTAGATCACACACAGTTTCTTTG 
EcoRI hINF2 fw 2 ATATATGAATTCATGTCGGTGAAGGAGGGC 
EcoRI hINF2 fw 3 ATATATGAATTCATGTCGGTGAAGGAGGGCGCACAG 
hINF2 NLS1 mut fw GCGCGCGAATTCCGGGCCGCTGCAGAGCCCAAGGAGATCACT
TTC 
hINF2 NLS2 mut rev GCGCGCACTAGTCTAAGCTGCAGCCTCTGCCTTCGCCGCCTGC
TCCTTC 
hINF2 NLS3 mut fw GCGCGCGAATTCCGGGCCTCAAAGGGGACCGGGGCTGCAGC
TGCAGCTGCACCCTCCAGGAGCCAGGAAGAGGTTC 
hINF2_2 NLS3 mut rev GCGCGCACTAGTCTACTTGGCCTTGGGCCTGGGCCTGAG 
hINF2 FH2 I643R CGATGCCAAGAAGAGCCTGAACCTCAACAGATTCCTGAAGCA
ATTTAAGTGCTCCAACGAGGAGGTC 
hINF2 FH2 K792A GATCAGCACATTGCTGAAGCTCACGGAGACCGCATCCCAGCA
GAACCGCGTGACGCTGCTGCAC 
hINF2 NES1 fw GCGCGCGAATTCCTGCTGGAGGCGCTGGCGCGGCTGTCGGG
CCGCGGC 
hINF2 NES1 rev GCGCGCACTAGTCTAGCCGCGGCCCGACAGCCGCGCCAGCGC
CTCCAGCAG 
hINF2 NES2 fw GCGCGCGAATTCCTGGCTCGCCTGCGAGACCTGGAG 
hINF2 NES2 rev GCGCGCACTAGTCTAAGCCTCCAGCTGGATCAGCAGGTC 
hINF2 NES3 fw GCGCGCGAATTCCTCCTTAAGCTCCTTCCCGAGAAGCACGAG
ATT 
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hINF2 NES3 rev GCGCGCACTAGTCTAAATCTCGTGCTTCTCGGGAAGGAGCTT
AAGGAG 
hINF2 NES4 fw GCGCGCGAATTCATGAAGGCTTTCCGGGACCTTTTCCTCCGCG
CCCTG 
hINF2 NES4 rev GCGCGCACTAGTCTACAGGGCGCGGAGGAAAAGGTCCCGGA
AAGCCTTCAT 
hINF2 NES4 mut fw GCGCGCGAATTCATGAAGGCTTTCCGGGACCTTTTCGGACGC
GCCCTG 
hINF2 NES4 mut rev GCGCGCACTAGTCTACAGGGCGCGTCCGAAAAGGTCCCGGA
AAGCCTTCAT 
hINF2 DAD 3LA long CAGGAGGAGGTGTGTGTCATCGATGCCGCTGCTGCTGACATC
AGGAAGGGCTTCCAGGCTCGGAAGACAGCCCGGGGCCGCGG
GGACACCGAC 
hINF2 DID E184K rev 
long 
GTAGGGCACGTTGTCGCTGCCGGAGAGCTTGTTCATGACAAT
GCTGAAGCGGTACTG 
hINF2 DID R218Q rev 
long 
CAGCAGCTGCAGCCCGATAAACTCGTTTTGCAGCTGGGTGCG
CGCGCGCAGGTCCTC 
hINF2 +CAAX EcoRI rev GCGCGCGAATTCCTATTACTGGATCACACACAGTTTC 
hINF2 –CAAX EcoRI rev GCGCGCGAATTCCTATCACTTGGCCTTGGGCCTGGGCCTG 
 
3.3.2 Agarose gel electrophoresis 
The DNA samples (PCR fragments, digested vectors, etc.) were mixed with DNA loading 
dye and loaded onto 0.8% - 2% agarose gels (depending on the size of the DNA 
fragments) in 1x TAE buffer containing 10 µg/µl ethidium bromide. The DNA fragments 
were separated electrophoretically under constant voltage using a DNA 
electrophoresis chamber (BioRad). The separated DNA fragments were detected under 
UV light using an INFINITY gel documentation system (peQlab). Seperated DNA bands 
were cut from the gel and extracted by the NucleoSpin® gel and PCR clean-up kit 
(Marcherey-Nagel). 
3.3.3 RNA isolation from cells 
Target cells were washed with ice cold PBS and lysed by addition of 1 ml TRIzol reagent 
(Thermo Fisher Scientific) directly to the 3.5 cm cell culture dish. Cells were then 
collected in a tube and vortexed thoroughly. Afterwards, 200 µl Chloroform were 
added to the cell lysate, followed by 15 sec of rigorous vortexing and incubation for 2 
min at 4°C. Samples were then centrifuged at 12,000 g for 15 min at 4°C to obtain 
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phase separation. The RNA, residing in the upper aqueous phase, was carefully 
transferred to a fresh tube and mixed with 500 µl isopropanol for RNA precipitation. 
After incubation for 30 min on ice, RNA was pelleted by centrifugation at 12,000g for 
15 min at 4°C. The RNA pellet was washed carefully with 75% Ethanol and pelleted 
again at 12,000g for 5 min at 4°C. The pellet was then dried at RT and dissolved in 15 – 
45 µl RNAse-free H2O.  
3.3.4 CRISPR/Cas9 mediated deletion of INF2 
To delete both isoforms of the INF2 gene in NIH3T3 cells by using an all-in-one 
CRISPR/Cas9 vector system (Sakuma et al., 2014), cells were transfected with the 
pX330A-1x2 vector  encoding for two different guide RNAs (gRNAs) directed towards 
the INF2 coding region. The vector additionally contains a 2A-eGFP fragment from 
pSpCas9(BB)-2A-GFP (Ran et al., 2013). The following oligonucleotides were taken into 
account: #1: CCCGAGTAGTTGACCACCGAGGG, #2: GCCCGAGTAGTTGACCACCGAGG, 
#14: CGCCTGGAGAGCAGCGATGGCGG, #15: TGGAGAGCAGCGATGGCGGCTGG. All 
sequences are localized in exon2.  The particular gRNA combinations were used to 
obtain an all-in-one vector harboring double gRNA cassettes: #1 & #14 (Clone 2), #2 & 
#14 (Clone 3) and #2 & #15 (Clone 4). The empty vector was used to generate control 
cells. The successful INF2 gene deletion was validated by immunoblotting against 
endogenous INF2. The whole process of generating INF2-depleted NIH3T3 cells was 
planned and conducted by Eva-Maria Kleinschnitz with the aid of Andrea Wüstenhagen 
and Marga Losekam (all AG Grosse).  
 
3.4 Immunofluorescence and microscopy 
3.4.1 Immunofluorescence microscopy sample preparation and staining 
Cells grown on glass coverslips were fixed with 3.7% formaldehyde in PBS for 10 min at 
room temperature (RT). Upon washing the coverslips three times with PBS, cells were 
permeabilized with 0.2% Triton X-100 in PBS (PBST) for 5 min at RT or, when 
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specifically indicated, with 0.05% Saponine in PBS for 5 min at RT. Afterwards, cells 
were blocked in 5% FCS/PBST (or 5% FCS/PBS, if permeabilized with Saponine) for 20 
min at RT and subsequently incubated with the particular antibodies (antibodies used 
in this study see Table 4). Primary antibody incubations were performed in 5% 
FCS/PBS(T) for 60 min at RT, followed by three washing steps with PBS(T). If necessary, 
cells were incubated then with Alexa Fluor-labeled secondary antibodies in 5% 
FCS/PBS(T) for 60 min at RT, followed by an optional incubation step for 10 min with 
DAPI (50x in PBS(T)). After three final washing steps with PBS(T), the coverslips were 
mounted on glass slides with fluorescent mounting medium (DAKO).  
3.4.2 Visualization of nuclear F-actin in fixed cells with phalloidin 
Visualization of nuclear actin filaments using phalloidin was performed as described 
previously (Baarlink et al., 2013). Briefly, NIH3T3 cells were grown at low density on 
glass coverslips. Cells were washed once with PBS and initially fixed with 0.5% TX-100 
and 0.25% Glutaraldehyde in cytoskeleton buffer for 1 min. A second fixation step was 
performed subsequently for 15 min with 2% Glutaraldehyde in cytoskeleton buffer. 
Upon washing the coverslips three times with cytoskeleton buffer, autofluorescence 
was quenched by treatment with 1 mg/ml freshly prepared NaBH4  for 5 min at RT. 
Afterwards, cells were washed again three times with cytoskeleton buffer and 
incubated with Alexa Fluor 488 conjugated phalloidin (1:400 in cytoskeleton buffer) for 
30 min. The coverslips were finally washed three times with cytoskeleton buffer and 
three times with ultrapure bidest H2O, followed by mounting on a glass slide with 
fluorescent mounting medium.  
3.4.3 Microscopy and image analysis 
All images were collected with an LSM 700 confocal microscope (Zeiss), equipped with 
a 63X, 1.4 NA oil objective and the ZEN 2012 software (Zeiss). The images were later 
processed for contrast enhancement and background noise reduction with ZEN 2012 
(Zeiss) or ImageJ/Fiji (National Institutes of Health).  
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To analyze the nucleocytoplasmic ratio of putative INF2-NES or INF2-NLS sequences, 
confocal Z-stacks of single cells were imaged and the maximum intensity projections 
were calculated with ZEN 2009 (Zeiss). The quantification of the nucleocytoplasmic 
ratio was performed by using ImageJ (National Institutes of Health), applying the 
IntensityRatioNucleiCytoplasm-Macro (http://dev.mri.cnrs.fr/projects/imagej-macros/ 
wiki/Intensity_Ratio_Nuclei_Cytoplasm_Tool). 
Nuclear fluorescence intensity measurements were conducted by analyzing confocal Z-
stacks of α-INF2 and DAPI stained NIH3T3 cells (Control vs. INF2-deleted cells) with the 
Imaris 8.3.1 software (Bitplane). All images were taken with the same microscope 
settings. Quantitative analysis of the confocal images was done by Matthias Plessner 
(AG Grosse). 
3.4.4 Live cell imaging 
For live cell imaging, cells were grown and transfected in 3.5 cm glass bottom dishes 
(MatTek). Live cell imaging was performed at 37 °C in a CO2 (5%) humidified chamber 
using an LSM700 confocal microscope with a 63×/1.4 oil objective in combination with 
the ZEN 2012 software (Zeiss).  
SNAP-Cell 647 SiR labeling was performed according to the manufacturer’s protocol 
(New England Biolabs). Briefly, cells were pre-seeded on glass bottom dishes and 
transfected with the appropriate plasmids the day before analysis. Prior visualization 
under the confocal microscope, SNAP-Cell 647 SiR loading dye was applied 1:400 and 
cells were incubated for 30 min at 37 °C in 5% CO2.  
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3.5 Biochemical methods 
3.5.1 SDS- polyacrylamide gel electrophoresis (SDS-PAGE) and protein 
immunoblotting (Western blot) 
Proteins were denatured by adding 2x Laemmli buffer either directly to cells in cell 
culture plates or to already prepared samples from co-immunoprecipitation or 
fractionation experiments. The samples were then collected in a tube and boiled for 10 
min at 95°C. Afterwards, the lysate was cleared by centrifugation at 16,000g for 10 
min. The samples were then either immediately subjected to SDS-PAGE or stored at -
20°C.  
The denatured proteins were separated by SDS-PAGE using a Mini-PROTEAN III Cell gel 
system (Bio-rad). Therefore, the samples were loaded to a polyacrylamide gel, which 
had to be casted before. The separating gels were casted in concentrations of 8%, 10% 
or 13%, depending on the sizes of the proteins to be separated. The proteins were 
then electrophoretically separated by applying a constant voltage to the gel (80 V for 
proteins inside the stacking gel and 120 V upon entering the separating gel).  
The separated proteins on the polyacrylamide gel were then transferred to a 0.45 µm 
nitrocellulose membrane (Whatman) by applying constant 350 mA for 1 h to 1.5 h 
using a Mini Trans-Blot® Electrophoretic Transfer Cell system (Bio-Rad). After 
successful protein transfer to the nitrocellulose membrane, checked by Ponceau S 
staining, membranes were incubated in blocking buffer (5% Milk in TBST) for 1 h at RT. 
The membrane was then incubated in blocking buffer containing the proper diluted 
primary antibody (see Table 4) either at 4°C o/n or for 1 h at RT. After washing the 
membrane three times for 10 min with TBST, it was incubated for 1 h at RT with 
secondary horseradish peroxidase (HRP)-conjugated antibodies diluted in blocking 
buffer. Membranes were then washed again three times for 10 min with TBST before 
analysis. Antibody labeled protein bands were detected by applying ECL reagent to the 
nitrocellulose membrane and exposing X-Ray films to the membrane inside a dark 
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room. Finally, the films were developed with an X-Ray film processor (Medical Index 
GmbH).  
3.5.2 Co-immunoprecipitation  
HEK293 or NIH3T3 cells were grown in 10 cm dishes and transfected with 2.5 µg of 
DNA. Upon a single wash with ice-cold PBS, cells were lysed in RIPA buffer 
supplemented with COMPLETE protease inhibitors. The lysate was incubated for 10 
min on ice and centrifuged for 10 min at 12,000g at 4°C. The supernatant, containing 
the debris-cleared lysate, was incubated afterwards with α-FLAG pre-coupled agarose 
beads (Sigma-Aldrich) or α-MYC pre-coupled agarose beads (Sigma-Aldrich) for 1.5 h at 
4°C. The beads were then washed three times with RIPA buffer and finally lysed in 2x 
Laemmli buffer. Prior boiling the samples for 5 min, they were subjected to SDS-PAGE 
and immunoblotting using HRP-conjugated α-FLAG or α-MYC antibodies.  
3.5.3 Subcellular fractionation 
The preparation of subcellular fractionations was adapted from (Kosugi et al., 2009). 
NIH3T3 cells were grown and transfected in a 10 cm cell culture plate. Prior lysis, cells 
were washed once with ice-cold PBS, dislodged and pelleted for 5 min at 800g. The cell 
pellet was resuspended in cell lysis buffer and allowed to swell on ice for 15-20 min 
with intermittent gentle vortexing. Finally, a 10 s vortexing step was conducted to 
disrupt all cell membranes. The supernatant, containing the cytoplasmic extract, was 
collected upon centrifugation of the total cell lysate for 10 min at 4°C at 12,000g. The 
pelleted nuclei were then washed once in cell lysis buffer before resuspension in 
nuclear lysis buffer, followed by incubation for 30 min on ice. The supernatant, now 
containing the nuclear extract, was collected after sedimentation of the remaining 
insoluble debris for 15 min at 4°C at 12,000g. 2x Laemmli sample buffer was then 
added to aliquots of the cytoplasmic and nuclear extracts. The samples were then 
subjected to SDS-PAGE with subsequent immunoblotting using appropriate primary 
antibodies and HRP-conjugated secondary antibodies. The purity of obtained extracts 
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was controlled by immunoblotting for α-tubulin or α-HDAC2 as cytoplasmic or nuclear 
markers, respectively.  
3.5.4 MRTF/SRF luciferase reporter assay 
MRTF/SRF luciferase reporter assays were performed as described before (Brandt et 
al., 2009) using pGL3D.AFOS and pRL-TK reporter plasmids. MRTF/SRF activity 
experiments were generally conducted in HEK cells, unless stated otherwise. Briefly, 4 
to 5 h after transfection of pre-seeded cells with pGL3D.AFOS and pRL-TK, together 
with plasmids carrying the genes of interest, cells were starved in DMEM containing 
0.25 % FCS for 16 to 24 hours before analysis. If alterations in MRTF/SRF 
transcriptional activity upon serum stimulation were measured, cells were stimulated 
prior analysis with 20% FCS for 6 hours.  
For sample preparation, cells were washed once with PBS and lysed by the addition of 
200 µl ice-cold passive lysis buffer (Promega) per 3.5 cm dish. Afterwards, cells were 
scraped and transferred to a tube, followed by incubation on ice for 20 min and 
centrifugation at 20,000 g for 10 min at 4°C. Dependent on the transfection efficiency, 
5 to 20 µl of the debris cleared cell lysate were used for measurements. The reporter 
assays were performed using the Dual-Luciferase® Reporter Assay System Kit 
according to the manufacturer’s protocol. The firefly and renilla luciferase signals were 
measured sequentially by a LuminoskanTM Ascent Microplate Luminometer (Thermo 
Scientific) using the AscentTM Software (Thermo Scientific). Afterwards, the firefly 
signal was normalized to the renilla signal in each sample.  
 
3.6 Statistics 
Statistical analysis was performed using GraphPad Prism 6 (GraphPad Software). Data 
is displayed as mean (± SD). The statistical significance was evaluated using the 
unpaired Student t test. Statistical significance is defined at P ≤ 0.05.   
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4. Results 
Formin proteins represent the largest group within different classes of actin 
nucleators. Up to date, 15 formin members have been discovered in vertebrates which 
can further be divided into several subgroups. Among those subgroups, Diaphanous-
related formins (DRFs) form the largest subset (Breitsprecher and Goode, 2013). 
Typically, DRFs exist in an autoinhibited state within cells, mediated by an interaction 
of the N-terminal diaphanous inhibitory domain (DID) and the C-terminal diaphanous 
autoregulatory domain (DAD) (Baarlink et al., 2010). Relieve of this intramolecular 
inhibition results in activation of formins and subsequent nucleation and elongation of 
unbranched actin filaments (Pruyne et al., 2002).  
Recently, a role of formins in the formation of F-actin structures in mammalian somatic 
cell nuclei was described (Baarlink et al., 2013; Belin et al., 2015). However, the 
appearance of additional formins in the nucleus as well as their putative participation 
in the assembly of nuclear actin filaments remained elusive.  
 
4.1 A novel approach to activate endogenous mDia formins  
Previously, it was revealed that the overexpression of an isolated mDia-DAD competes 
with the intramolecular inhibitory interaction of DID and DAD of endogenous mDia 
formins, leading to the release of mDia autoinhibition and subsequent actin 
rearrangement (Alberts, 2001). Based on the finding that essential DAD-binding amino 
acids are mostly located on the concave surface of the Armadillo Repeat Region (ARR) 
(Otomo et al., 2005a), we wanted to analyze if expression of an isolated ARR (here 
referred to as DID) also inhibits mDia formins to revert to their intramolecular 
autoinhibited state (working model see Figure 8). This approach would expand the 
tools available for endogenous formin activation in trans. Thus, we generated 
constructs genetically encoding the DIDs of either mDia1 (aa 149-397), mDia2 (aa 129-
369) or mDia3 (aa 163-399) and tested their functionality.  
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Figure 8: Release of formin autoinhibition by expression of DAD or DID 
Cartoon illustrating the activation of endogenous mDia2 by overexpression of mDia2-DAD (Alberts, 
2001) (light green) or mDia2-DID (light blue, amino acids 32 – 266, comprising the armadillo repeat 
region of mDia2). Overexpressed mDia2-DAD or -DID interferes with DID/DAD interaction in 
autoinhibited mDia2, thereby releasing its autoinhibition and promoting actin assembly.   
 
4.1.1 Expression of the DID of mDia formins drives MRTF/SRF transcriptional activity 
Activation of mDia caused by overexpression of its DAD mediates actin remodeling and 
subsequent MRTF/SRF transcriptional activity (Alberts, 2001). To analyze successful 
DID mediated activation of mDia formins, we investigated the effects of mDia-DID 
expression on actin dynamics by performing a luciferase reporter gene assay to 
examine SRF activity (SRF reporter gene assays were performed in serum starved HEK 
cells, unless stated otherwise). Indeed, expression of mDia1-DID, mDia2-DID or mDia3-
DID led to a remarkable increase in SRF transcriptional activity, although the increase 
was not as striking as upon expression of mDia2-DAD (Figure 9A).  
Furthermore, actin polymerization promotes the release of G-actin from MRTF-A, 
resulting in nuclear accumulation of MRTF-A (Vartiainen et al., 2007).  Thus, we 
expected that overexpression of mDia-DID also mediates MRTF-A-shuttling to the 
nucleus. Indeed, the accumulation of MRTF-A-GFP in the nucleus of serum starved 
NIH3T3 cells could be visualized upon expression of mDia2-DID (Figure 9C, upper 
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panel). The DIDs of mDia1 and mDia3 have not been analyzed in terms of MRTF-A-
shuttling. 
 
4.1.2 The expression of mDia2-DID in the nucleus is capable of assembling a nuclear 
actin network 
The dynamic regulation of MRTF/SRF transcriptional activity is dependent on actin 
inside the nucleus (Vartiainen et al., 2007). Recently, a role of nuclear mDia formins in 
the regulation of MRTF/SRF activity was described (Baarlink et al., 2013). Spatial 
activation of mDia2 mediated by expression of the nuclear targeted mDia2-DAD was 
shown to induce the assembly of a nuclear actin network followed by MRTF-A 
accumulation in the nucleus and subsequent increase in MRTF/SRF transcriptional 
activity (Baarlink et al., 2013). 
Thus, we generated a nuclear targeted version of mDia2-DID (mDia2-DID-NLS) and 
analyzed the ability of the DID to activate endogenous mDia2 in the nucleus. Indeed, 
increased SRF activity (Figure 9B) and accumulation of MRTF-A-GFP in serum starved 
NIH3T3 cells (Figure 9C, lower panel) could be obtained upon expression of mDia2-DID-
NLS. The effect in MRTF/SRF transcriptional regulation was not as prominent as upon 
activation of mDia2 by mDia2-DID (cf. Figure 9A). However, this more moderate effect 
comparing mDia2-DID-NLS to mDia2-DID mediated SRF-activity was expected as 
nuclear mDia activation by mDia2-DAD-L1168G-NLS also resulted in a marginal 
increase in SRF activity compared to mDia2 activation by mDia2-DAD (Figure 9B and 
(Baarlink et al., 2013), cf. Figure 9A). Furthermore, by using the nuclear actin probe 
Actin-Chromobody-TagGFP2-NLS (referred to as nuclear-Actin-Chromobody-GFP or 
short as nAC-GFP) (Plessner et al., 2015) we could obtain clearly visible nuclear actin 
filaments upon activation of mDia2 in the nucleus by mDia2-DID-NLS (Figure 9D).  
Interestingly, co-expression of mDia2-DAD together with mDia2-DID prevented 
alterations in SRF activity (Figure 9E, left panel). The same effect could be obtained 
using nuclear targeted versions of mDia2-DAD and mDia2-DID (Figure 9E, right panel). 
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This suggests that both overexpressed constructs interact with each other within cells, 
thereby inhibiting their ability to release autoinhibition of endogenous mDia.  
Taken together, these results strongly suggest that the expression of the isolated DID 
of mDia formins provides an additional tool to activate endogenous mDia by 
interacting with the DAD of the endogenous formin and thereby interfering with the 
intramolecular mDia autoinhibition.  
 
Figure 9: mDia-DID mediated regulation of actin dynamics and MRTF/SRF transcriptional activity  
A) HEK cells were transfected with mDia1-DID, mDia2-DID or mDia3-DID together with the MRTF/SRF 
reporter 3DA.luc to analyze effects on SRF activity. mDia2-DAD was used as a positive control (and for 
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comparison). Transfected cells were grown under serum starved conditions (DMEM with 0.25 % FCS) 
before conducting the SRF reporter gene assay. Results are means ± SD (n=3). B) SRF activity in HEK cells 
expressing mDia2-DAD-L1168G-NLS (used as positive control) or mDia2-DID-NLS. Results are means ± SD 
(n=3). C) NIH3T3 cells were transfected with MRTF-A-GFP together with either mCherry-mDia2-DID or 
mCherry-mDia2-DID-NLS and imaged under serum starved conditions. Scale bar, 10 µm. D) 
Representative images show NIH3T3 cells expressing mCherry-mDia2-DID-NLS together with Actin-
Chromobody-TagGFP2-NLS (= nuclear-Actin-Chromobody [nAC-GFP]). Scale bar, 10 µm. E) mDia2-DID 
inhibits mDia2-DAD driven SRF activity. HEK cells were transfected with 500 ng of either mDia2-DAD (left 
panel) or mDia2-DAD-L1168G-NLS (right panel). mDia2-DAD expressing cells were co-transfected with 
increasing amounts of  mDia2-DID, whereas mDia2-DAD-L1168G-NLS expressing cells were transfected 
with mDia2-DID-NLS (+: 250 ng, ++: 500 ng). The transfected amount of DNA was filled to a total of 2 µg 
with empty vector. Results are means ± SD (n=3). 
 
4.2 INF2 participates in actin dynamics and MRTF/SRF transcriptional 
activity 
Next, we examined if the release of formin autoinhibition upon expression of the 
isolated DID is not restricted to mDia but rather if this elegant way of modulating 
endogenous formin activity ccould also be implemented in other DRFs.  
 
4.2.1 INF2-DID and INF2-DAD expression results in increased SRF activity and MRTF-A 
accumulation to the nucleus 
We conducted a MRTF/SRF reporter gene assay screen upon expression of DIDs of 
other DRFs (hFMNL1: aa 75-399, hFMNL2: aa 71-391, hFMNL3: aa 74-395, hFHOD1: aa 
115-341, hFHOD3: aa 103-332 and hINF2: aa 32-266) to analyze if they behave in an 
mDia-DID comparable manner. A striking upregulation of SRF activity could be seen in 
serum starved HEK cells expressing hINF2-DID, whereas expression of the respective 
other DIDs showed no impact on MRTF/SRF regulation (Figure 10A). The DID of the 
mouse INF2 homologue, featuring 95% sequence homology to hINF2-DID, activated 
MRTF/SRF transcription similar to hINF2-DID (data not shown).  
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Furthermore, we wanted to analyze if INF2 autoinhibition could also be released by 
overexpression of its DAD. Thus, we generated three different versions of the INF2-
DAD: INF2-DAD-core (containing the DAD/WH2 domain flanked by additional amino 
acids: aa 941-1015), hINF2-DAD (containing the full C-terminus of hINF2 starting N-
terminal of the DAD/WH2: aa 965-1240) and hINF2-DAD-CAAX (containing the full C-
terminus of hINF2-CAAX, aa 965-1249) (Figure 10B). Expression of either one of the 
INF2-DAD versions in HEK cells resulted in a striking upregulation of MRTF/SRF 
transcriptional activity (Figure 10C). However, expression of full length hINF2 or hINF2-
CAAX alone displayed only moderate SRF activity, leading to the assumption that 
overexpressed full length INF2 mainly exists in an autoinhibited state in unstimulated 
cells. Co-expression of full length hINF2 or hINF2-CAAX together with the DAD of the 
respective isoform raised MRTF/SRF transcriptional activity almost to levels which 
were obtained by expression of constitutively active hINF2-A149D or hINF2-A149D-
CAAX (Korobova et al., 2013; Ramabhadran et al., 2013) (Figure 10D). The INF2-DAD-
core mediated increase in MRTF/SRF transcriptional activity could be suppressed by 
co-expression of hINF2-DID (Figure 10E). 
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Figure 10: INF2-DID or INF2-DAD expression modulates SRF activity  
A) SRF activity was compared upon transfection of HEK cells with the DID domain of distinct formins. 
Note that only the DID of INF2 (amino acids 32 – 266) shows a striking increase in MRTF/SRF dependent 
gene regulation. Results are means ± SD (n=3). B) The cartoon shows an illustration of the C-terminus of 
hINF2, comprising the DAD/WH2 domain (shown in red). Residues in purple indicate highly conserved 
amino acids among WH2 domains of other proteins (Chhabra and Higgs, 2006). Different variants of 
hINF2-DAD were used in this study: INF2-DAD-core (amino acids 941 – 1015), as well as the full C-
termini of both hINF2 isoforms: hINF2-DAD (amino acids 965 – 1240) and hINF2-DAD-CAAX (amino acids 
965 – 1249). C) HEK cells were transfected with INF2-DAD-core, hINF2-DAD or hINF2-DAD-CAAX and SRF 
activity was analyzed. Results are means ± SD (n=3). D) To analyze the efficiency of DAD mediated INF2 
activation, SRF activity was measured in HEK cells expressing the respective isoforms of hINF2, hINF2 
together with hINF2-DAD or constitutive active hINF2-A149D. 500 ng of each construct were 
transfected. Results are means ± SD (n=3). E) hINF2-DID inhibits INF2-DAD-core driven SRF activity. SRF 
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mediated transcription was measured in HEK cells transfected either with INF2-DAD-core or hINF2-DID 
alone or co-transfected with INF2-DAD-core together with equal amounts of hINF2-DID. Results are 
means ± SD (n=3).  
Activation of hINF2 by its DID or DAD expression also resulted in translocation of 
MRTF-A-GFP to the nucleus in serum starved NIH3T3 cells (Figure 11A). For 
comparison, similar outcomes could be obtained upon expression of hINF2-A149D or 
hINF2-A149D-CAAX (Figure 11B) by observing nuclear accumulation of a truncated 
form of MRTF-A containing only the RPEL domain (Guettler et al., 2008) which controls 
the nucleocytoplasmic shuttling of MRTF-A.  
Noteworthy, successful INF2-DAD mediated activation of endogenous INF2 was 
reported recently (Bartolini et al., 2016). Thereby a role of INF2 in the formation of 
stabilized detyrosinated microtubules was suggested.  
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Figure 11: INF2-DID or INF2-DAD expression regulates translocation of MRTF-A to the nucleus 
A) Serum starved NIH3T3 cells show MRTF-A-GFP localized to the nucleus upon expression of mCherry-
hINF2-DID, mCherry-INF2-DAD-core as well as mCherry-hINF2-DAD or mCherry-hINF2-DAD-CAAX. The 
right panel shows the localization of MRTF-A-GFP in serum starved NIH3T3 cells (without INF2 
activation). Scale bar, 10 µm. B) 3xRPEL 2xBFP was used as indicator for MAL shuttling in serum starved 
NIH3T3 cells with constitutive active INF2 (GFP-hINF2-A149D or GFP-hINF2-A149D-CAAX). The right 
panel shows the localization of 3xRPEL-2xBFP in serum starved NIH3T3 cells (without INF2 activation). 
Scale bar, 10 µm.  
 
4.2.2 Distinct versions of INF2-DAD lead to selective activation of hINF2 isoforms 
Selective activation of the respective hINF2 isoforms upon expression of hINF2-DAD or 
hINF2-DAD-CAAX could be shown by analyzing the effects on the reorganization of the 
actin cytoskeleton. Using LifeAct-GFP as actin detection probe, we observed that 
hINF2-DAD expression led to a distinct cytosolic actin pattern while hINF2-DAD-CAAX 
resulted in actin structures localizing to the ER surface (Figure 12A). The differential 
actin pattern could also be visualized in fixed NIH3T3 cells by phalloidin staining (Figure 
12B). These differences are consistent with the previously reported distinct actin 
rearrangement upon expression of constitutively active INF2 isoforms ((Ramabhadran 
et al., 2013) and Figure 12C). Interestingly, hINF2-DAD-CAAX did not mediate actin 
rearrangement to the ER in HELA cells (data not shown) where the INF2-CAAX isoform 
could only be detected in very low amounts (Ramabhadran et al., 2011).  
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Figure 12: Differential isoform specific INF2-DAD derivatives selectively activate particular hINF2 
isoforms 
A) NIH3T3 cells expressing either mCherry-hINF2-DAD or mCherry-hINF2-DAD-CAAX together with 
LifeAct-GFP resemble a characteristic and distinct actin pattern (blue arrowhead: perinuclear actin ring 
upon activation of hINF2-CAAX). The right panel shows the actin pattern visualized by LifeAct-GFP in 
untransfected NIH3T3 cells. Scale bar, 10 µm. B) The distinct actin pattern upon expression of either 
INF2-DAD or INF2-DAD-CAAX can also be detected in fixed NIH3T3 cells. F-actin was labeled by Alexa 
Fluor 488 conjugated Phalloidin (Phalloidin AF488). The yellow arrowhead indicates the INF2-DAD-CAAX 
mediated characteristic perinuclear actin structure. Scale bar, 10 µm. C) Images show GFP-hINF2-A149D 
or GFP-hINF2-CAAX-A149D expressing NIH3T3 cells. LifeAct mCherry was co-transfected as a marker for 
Actin. Note the characteristic INF2-CAAX (pink arrowhead) and Actin (yellow arrowhead) pattern in the 
perinuclear region. Scale bar, 10 µm. 
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4.2.3 INF2-DID or INF2-DAD mediated effects on actin rearrangement and MRTF/SRF 
regulation are dependent on endogenous INF2 
The above described INF2-DID or INF2-DAD mediated effects on cellular properties had 
to be characterized in terms of their specificity. Initially, point mutations were 
introduced in either the DID (A149D (Ramabhadran et al., 2013), E184K or R218Q 
(Brown et al., 2010)) or the DAD (L1008A, L1009A, L1018A [= 3LtoA] (Chhabra and 
Higgs, 2006)) which were suggested to disrupt INF2-DID/DAD binding and subsequent 
INF2 autoinhibition (Rollason et al., 2016). All mutations were shown to compensate 
for the increase in MRTF/SRF transcriptional activity induced by INF2-DID or INF2-DAD 
(Figure 13A). This functional deficits seems to be due to the loss of binding ability of 
mutated DID or DAD to their particular counterpart, as detected by Co-
Immunoprecipitation (Figure 13B). hINF2-DID/DAD binding studies by Co-
Immunoprecipitation were already conducted elsewhere (Rollason et al., 2016). 
However the length of the hINF2-DID construct in our study is remarkably shorter in 
length (aa 32-266, containing solely the ARR) than the construct used in (Rollason et 
al., 2016) (aa 14-343), therefore we decided to specify the binding abilities of the INF2-
DID as well as DAD constructs used in this study.  
 
Figure 13: Mutations interfering with INF2-DID/DAD binding inhibit regulation of SRF activity 
A) HEK cells were transfected with either hINF2-DID (wt, or with the mutations A149D, E184K or R218Q) 
or hINF2-DAD ‘core’ (wt or L1008A, L1009A, L1018A [= 3LtoA]). Measurements of SRF activity were 
conducted in serum starved cells. Results are means ± SD (n=3). B) Co-Immunoprecipitations from cells 
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expressing hINF2-DID (or derivatives) or INF2-DAD-core (or derivatives) were immunoblotted as 
indicated.  
Furthermore, it had to be determined if the rearrangement of the actin structures 
upon overexpression of INF2-DAD or INF2-DAD-CAAX (cf. Figure 12A) were mediated 
by activation of the respective endogenous INF2 isoform or rather by the expression of 
the DAD itself or even by a putative influence of the DAD on other proteins. Thus, we 
tested if hINF2-DAD-CAAX overexpression affects the actin pattern in siRNA mediated 
INF2 knockdown cells compared to control cells (knockdown efficiency see Figure 14A). 
In siControl cells, the majority of hINF2-DAD-CAAX transfected cells showed 
characteristic active INF2-CAAX actin structures, whereas upon INF2 depletion, the 
amount of INF2-DAD-CAAX transfected cells featuring an ER localized actin pattern 
decreased strikingly (Figure 14B).  
Moreover, we used the CRISPR/Cas9 system to obtain a complete deletion of INF2 in 
NIH3T3 cells. Efficient knockout of endogenous INF2 in different NIH3T3 clones was 
finally proven by immunoblotting (Figure 14C) as well as in selected clones by confocal 
microscopy using α-INF2-immunolabeling (Figure 14D). Interestingly, INF2 knockout 
led only to a decreased but not completely abolished INF2-DAD-core driven MRTF/SRF 
transcriptional activity (Figure 14E). Co-expression of INF2-DAD-core together with full 
length hINF2 could rescue the effect on SRF activity. Noteworthy, this co-expression in 
INF2-knockout cells resulted in lower SRF activity than in control cells. The difference 
might reflect the effect of activated endogenous INF2 in control cells which is depleted 
in INF2 knockout cells. The reduction of MRTF/SRF transcriptional activity upon INF2-
DAD expression in INF2 depleted cells goes along with reduced MRTF-A-GFP 
accumulation in the nucleus (Figure 14F). Again, the reduced MRTF-A shuttling could 
be partially rescued upon co-expression of hINF2-DAD together with full length hINF2.  
Noteworthy, INF2 depletion remarkably interfered with serum-induced SRF activity 
(Figure 14G). Thus, INF2 seems to be required to efficiently activate general SRF 
transcriptional activity by serum.  
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Figure 14: INF2-DID or INF2-DAD promoted effects on actin dynamics and MRTF/SRF regulation 
depend on endogenous INF2 
A) Efficient siRNA mediated depletion of mINF2 in NIH3T3 cells was proven by immunoblotting against 
INF2 upon treatment with four different siRNA sequences. All four sequences are capable to silence 
both isoforms of INF2 simultaneously. α-Tubulin detection was used as loading control. B) INF2 silenced 
NIH3T3 cells were quantified for showing formation of characteristic hINF2-DAD-CAAX mediated F-actin 
structures, compared to siControl cells. Only cells expressing mCherry hINF2-DAD-CAAX were 
considered for quantification. Around 25 to 40 cells were analyzed for each condition in two 
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independent experiments. C) Efficient CRISPR/Cas9 mediated depletion of both isoforms of INF2 in 
NIH3T3 cells was proven by immunoblotting against INF2 in different clones (bold: clones used for 
further experiments). α-Tubulin detection was used as loading control. D) Representative confocal 
images (single z-stack section) illustrate α-INF2 immunolabeling of selected NIH3T3 INF2 knockout 
clones. White dashed lines delineate nuclear borders (cells were counterstained with DAPI – Data not 
shown). Scale bar, 10 µm.  E) INF2 depleted NIH3T3 cells (control vs. clone 2/2 or 4/5) were transfected 
with either hINF2 alone, hINF2-DAD-core or hINF2-DAD-core together with hINF2. SRF activity was 
analyzed under serum starved conditions. Results are means ± SD (n=3). F) INF2 depleted NIH3T3 cells 
(control, clone 2/2 and clone 4/5) were transfected with either MRTF-A-GFP alone, MRTF-A-GFP 
together with mCherry-hINF2-DAD or MRTF-A-GFP together with mCherry-hINF2-DAD and MYC-hINF2 
and imaged under serum starved conditions. Localization of MRTF-A-GFP was analyzed in around 55 to 
100 cells for each condition in two independent experiments. G) NIH3T3 cells lacking INF2 were grown 
under serum starved conditions. Cells were stimulated with 20 % FCS 6 h before conducting the SRF 
reporter gene assay. Results are means ± SD (n=3).  
 
4.3 INF2 localizes to the nucleus 
Previous work revealed localization of mDia formins in the nucleus (Baarlink et al., 
2013; Miki et al., 2009). We examined by subcellular fractionation if the formin INF2 
also localizes to the nucleus. Indeed, immunoblotting revealed presence of 
endogenous INF2 in nuclear fractions of NIH3T3 cells (Figure 15A). Moreover, 
endogenous nuclear INF2 could also be detected by confocal microscopy. The nuclear 
INF2 fluorescence intensity was strikingly reduced in INF2 deleted cells compared to 
control cells (Figure 15B). 
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Figure 15: INF2 localizes to the nuclear compartment 
A) Subcellular fractions of NIH3T3 cells were immunoblotted for endogenous INF2. α-Tubulin and α-
HDAC blotting was used as control for successful fractionation. B) The relative nuclear fluorescence 
intensity upon α-INF2 immunolabeling was quantified from NIH3T3 control cells and INF2 deleted 
NIH3T3 cells. Additional staining of control cells without α-INF2 antibody served as control for unspecific 
2nd antibody binding. The nucleus was highlighted with DAPI. Around 40 to 50 nuclei were analyzed for 
each condition in two independent experiments. Sample images are shown in Figure 14D. Results are 
means ± SD.  
 
4.3.1 INF2 contains functional NLS and NES motifs 
To gain details about the nuclear localization of INF2 we used the bioinformatics tool 
cNLS-Mapper (Kosugi et al., 2009) to detect putative nuclear localization sequences 
(NLS) in hINF2. Three putative NLS regions could be identified named NLS1 (aa 622 – 
651), NLS2 (aa 910 – 941) and NLS3 (aa 1213-1240 in the isoform lacking the CAAX 
motif and aa 1213 – 1248 present in INF2-CAAX) (Figure 16A). Subsequently, we 
generated constructs expressing the isolated aa sequence of the identified NLS fused 
to a GFP fluorophore. To determine if these putative NLS are functional, we expressed 
the diverse GFP-NLS constructs in NIH3T3 cells and quantified the ratio between the 
nuclear and cytoplasmic GFP signal (Figure 16B, C). NLS1-GFP and NLS2-GFP did not 
show an increase in the nucleocytoplasmic GFP-signal ratio compared to the signal of 
GFP alone. However, the majority of the signal of GFP-NLS3 (in both isoforms) could be 
detected in the nuclear compartment. Mutations in the sequence of both NLS3 at six 
positively charged key residues (K1220A, R1221A, R1222A, K1223A, K1224A, and 
R1225A) efficiently inhibited nuclear accumulation of GFP-NLS3.  
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Figure 16: INF2 contains putative NLS-like sequences  
A) Cartoon of distinct domains of hINF2 including three different putative nuclear localization sequences 
(NLS). Putative NLS were identified using cNLS mapper (Kosugi et al., 2009). Critical amino acids are 
highlighted in bold. Note the differences between the two isoforms in the sequence of NLS3. B) The 
ratio of the nuclear vs. the cytoplasmic GFP signal fused to each putative NLS as well as to the mutated 
NLS3 (K1220A, R1221A, R1222A, K1223A, K1224A, and R1225A). The average of 8 to 10 analyzed cells is 
shown. C) Left panel: Images of representative NIH3T3 cells show localization of GFP alone or GFP fused 
to the putative NLS3 (both isoforms). Right panel: Images display the localization of the K1220A, 
R1221A, R1222A, K1223A, K1224A, and R1225A mutant of NLS3 (of both INF2 isoforms) fused to GFP in 
NIH3T3 cells. mCherry-H2B was used as nuclear marker. Scale bar, 10 µm.  
Furthermore, bioinformatic analysis using NetNES 1.1 Server (la Cour et al., 2004) of 
the hINF2 amino acid sequence revealed multiple putative nuclear export signals (NES) 
named NES1 (aa 77-88), NES2 (aa 230-247), NES3 (aa 675-685) and NES4 (aa 913-924) 
(Figure 17A). Constructs encoding the isolated NES-like sequence fused to GFP were 
generated and expressed in NIH3T3 cells. Analysis of their nucleocytoplasmic GFP-
signal distribution revealed at least NES4 to be functional (Figure 17B, C). Interestingly, 
the amino acid sequence of NES4 in hINF2 shows some sequence homology to a well 
described NES-like sequence in the C-terminal mDia2 region containing the critical 
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residue L1168 (Miki et al., 2009) as well as to a putative NES sequence in FHOD1 
(Ménard et al., 2006). In hINF2 the corresponding amino acid is L921. Mutation of L921 
to Glycine blocks the export function of NES4.  
 
Figure 17: INF2 shows putative NES-like sequences 
A) Cartoon showing the protein domain structure of hINF2. Putative NES-like sequences (shown in pink) 
were identified using NetNES 1.1 Server (la Cour et al., 2004). A putative critical amino acid in NES4 is 
shown in bold. B) The ratio of nuclear vs. cytoplasmic GFP signal fused to each putative NES as well as to 
mutated NES4 (L921G). The average of 8 to 10 analyzed cells is shown. C) Representative images of 
NIH3T3 cells show the localization of GFP alone and GFP fused to NES4 or mutated NES4 (L921G). 
mCherry H2B was used as nuclear marker. Scale bar, 10 µm. 
These results suggest that INF2 contains functional NLS and NES motifs for putative 
nucleo-cytoplasmic shuttling. Previously, mDia2 was shown to continuously shuttle 
between the nucleus and the cytoplasm through a specific nuclear transport 
mechanism composed of importin-α/β and CRM1 (Miki et al., 2009). Notably, although 
isolated GFP-NES4 was enriched in the nucleus upon blocking CRM1 mediated nuclear 
export by leptomycin B (Figure 18A, B), neither endogenous hINF2 (Figure 18C) nor 
different full length hINF2 derivatives (Figure 18D) accumulated in the nucleus upon 
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LMB treatment. Thus we conclude that if INF2 continuously shuttles between the 
nucleus and the cytoplasm, it uses a nuclear transport machinery distinct from mDia2.  
 
Figure 18: INF2 does not accumulate in the nucleus upon LMB treatment  
A) Nucleocytoplasmic ratio of GFP-NES4 and GFP-NES4-L921G upon LMB treatment (25 nM, 1h). B) 
Representative images show the effect of LMB (25 nM, 1 h) on the localization of GFP fused to NES4 or 
the NES4-L921G mutant. Scale bar, 10 µm. C-D) Representative images show fixed NIH3T3 cells before 
or after treatment with 25 nM LMB for 3 hours. Cells were either immunostained for endogenous INF2 
(C) or tagged versions of both hINF2 isoforms (GFP: left panel, MYC: right panel) were expressed and 
visualized (D). Scale bar, 10 µm. 
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4.4 Nuclear INF2 regulates actin network assembly and MRTF/SRF 
activity 
Activated nuclear mDia promotes the formation of a nuclear actin network and 
subsequent regulation of SRF dependent gene expression (Baarlink et al., 2013). As we 
could detect INF2 also in the nucleus, we thus analyzed if spatially restricted activation 
of INF2 affects nuclear actin polymerization.  
 
4.4.1 Activation of INF2 within the nucleus leads to nuclear actin network assembly  
To activate endogenous INF2 in the nucleus, we generated NLS tagged versions of 
hINF2-DID or INF2-DAD-core to release INF2 autoinhibition. Phalloidin staining 
revealed nuclear actin structures upon expression of either hINF2-DID-NLS or INF2-
DAD-core-NLS in NIH3T3 cells (Figure 19A). Nuclear actin structures could also be 
obtained in living NIH3T3 cells by using the actin marker nAC-GFP upon expression of 
hINF2-DID-NLS or INF2-DAD-core-NLS (Figure 19B). Noteworthy, whereas a vast 
majority of INF2-DAD-core-NLS transfected cells displayed nuclear F-actin, fewer cells 
showed those structures upon hINF2-DID-NLS transfection. Expression of the DID 
binding deficient mutant INF2-DAD-core-3LtoA-NLS did not result in nuclear actin 
filament formation (Figure 19C), further underscoring the specificity of the approach. 
The formation of nuclear actin filaments upon INF2-DAD-core-NLS mediated activation 
of INF2 did not exclusively occur in NIH3T3 cells but could also be detected using nAC-
GFP in diverse other cell lines such as HELA, LOX or HT29 (Figure 19D). 
To refute the possibility that hINF2-DID-NLS or INF2-DAD-core-NLS overexpression is 
followed by an enrichment of actin monomers in the nucleus and thus leading to 
filament formation, subcellular fractionation experiments were conducted. However, 
no significant alterations in the abundance of endogenous actin in the nucleus could 
be obtained upon expression of neither nuclear hINF2-DID nor INF2-DAD-core (Figure 
19E).  
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Figure 19: Activation of nuclear INF2 mediates formation of an actin network in the nucleus 
A) Images show actin filaments visualized by Phalloidin-AF488 staining in fixed NIH3T3 cells expressing 
mCherry-hINF2-DID-NLS or mCherry-INF2-DAD-core-NLS. Note the distinctive nuclear actin structures 
visualized by Phalloidin-AF488. Scale bar, 10 µm. B) Nuclear actin structures upon expression of mCherry 
hINF2-DID-NLS or mCherry-INF2 DAD-core-NLS could also be visualized in living cells using nAC-GFP. 
Scale bar, 10 µm. C) NIH3T3 cells transfected with INF2-DAD-core-3LtoA-NLS do not show F-actin in the 
nucleus. Scale bar, 10 µm. D) Images show samples of nuclear actin structures visualized by nAC GFP in 
HELA, HT29 and LOX cells expressing mCherry-INF2-DAD-core-NLS. Note the differential actin pattern 
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comparing non-transfected to INF-2-DAD-core-NLS expressing (yellow arrowheads) cells.  Scale bar, 10 
µm. E) Immunoblotting for endogenous β-Actin upon subcellular fractionation does not reveal an 
accumulation of actin in the nucleus upon expression of either mCherry-hINF2-DID-NLS or mCherry-
INF2-DAD-core-NLS compared to mCherry-NLS alone.  
Noteworthy, a majority of INF2-DAD-core-NLS transfected cells exhibit a remarkable 
actin ring-like structure. However, in contrast to the INF2-CAAX mediated perinuclear 
actin ring (Ramabhadran et al., 2013), the INF2-DAD-core-NLS mediated actin ring-like 
structure at the nucleocytoplasmic border partially colocalizes with the nuclear lamina 
facing the nuclear interior (Figure 20A-C).  
Furthermore, we confirmed the intranuclear localization of the actin ring by using 
Saponine permeabilization, which removes cholesterol from membranes while leaving 
the nuclear membrane, which does not contain cholesterol intact (Adam et al., 1990). 
Upon Saponine permeabilization, INF2-DAD-core-NLS mediated actin structures could 
not be detected in the nucleus of GFP-Actin-NLS expressing NIH3T3 cells by 
immunostaining against GFP, as antibodies are incapable of entering the nuclear 
interior under these conditions (Figure 20D). Contrariwise, nuclear actin structures 
could be visualized by α-GFP immunostaining when cells were permeabilized with TX-
100. However, characteristic hINF2-DAD-CAAX mediated perinuclear actin structures 
could be detected in the cytoplasm in both permeabilization methods (data not 
shown).  
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Figure 20: INF2-DAD-core-NLS expression promotes formation of a prominent sublaminar actin ring-
like structure  
A) NIH3T3 cells expressing nAC-GFP were transfected with Lamin-Chromobody-BFP and mCherry-INF2-
DAD-core-NLS. White rectangles mark areas of higher magnification. The merged panel shows the 
localization of nAC GFP (white arrowhead) together with the Lamin-Chromobody-BFP signal (yellow 
arrowhead). Scale bar, 10 µm. B) NIH3T3 cells were transfected with mCherry-INF2-DAD-core-NLS 
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together with nAC-GFP and Lamin-Chromobody-SNAP (labeled with 647-SiR dye). An area of higher 
magnification (marked by white rectangles) is shown in the merged panel (white arrowhead: nAC GFP 
signal, yellow arrowhead: 647-SiR signal). Scale bar, 10 µm. C) Fixed NIH3T3 cells transiently expressing 
BFP-INF2-DAD-core-NLS were stained with Phalloidin-AF488 and for Lamin-A/C. The zoomed merged 
panel (correlating to white rectangles) displays nuclear actin structures (white arrowhead) and the 
nuclear lamina (yellow arrowhead). Scale bar, 10 µm. D) Fixed NIH3T3 cells expressing GFP-Actin-NLS 
and mCherry-INF2-DAD-core-NLS were permeabilized and stained as indicated. The yellow arrowheads 
point to remarkable INF2-DAD-core-NLS mediated ring-like nuclear actin structures detected by imaging 
the intramolecular GFP signal. Note that the ring-like structures could only be visualized by α-GFP 
immunolabelling upon cell permeabilization with 0.2 % TX-100 (orange arrowhead) but not upon 0.05 % 
Saponine treatment (blue arrowhead). Scale bar, 10 µm.  
 
4.4.2 Nuclear INF2 activation affects MRTF/SRF transcriptional activity 
Induction of INF2 mediated nuclear actin filaments also resulted in an increase in 
MRTF/SRF transcriptional activity (Figure 21A). Thereby, INF2-DAD-core-NLS 
expression upregulated SRF activity more effectively than hINF2-DID-NLS. Interestingly, 
the ability of translocation of MRTF-A to the nucleus was more effective upon DID 
mediated INF2 activation compared to DAD mediated activation (Figure 21B). 
 
Figure 21: Active nuclear INF2 mediates MRTF translocation and affects SRF activity  
A) HEK cells were transfected with INF2-DAD-core-NLS or hINF2-DID-NLS and SRF activity was measured. 
Results are means ± SD (n=3). ***: P<0.001, ****: P<0.0001, Student’s t-test. B) NIH3T3 cells were 
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transfected with MRTF-A-GFP and either mCherry-INF2-DAD-core-NLS or mCherry-hINF2-DID-NLS. Cells 
were analyzed then for the localization of MRTF-A-GFP. Scale bar, 10 µm. 
 
4.4.3 INF2-DAD mediated nuclear actin network assembly is INF2 dependent 
Measurements of MRTF/SRF transcriptional regulation in HEK cells expressing equal 
amounts of hINF2-DID-NLS or INF2-DAD-core-NLS together revealed compensation of 
the effects on SRF activity mediated by expression of hINF2-DID-NLS or INF2-DAD-core-
NLS alone (Figure 22A). Additionally, INF2-DAD-core-NLS expressing NIH3T3 cells were 
co-transfected together with hINF2-DID-NLS and analyzed for nuclear actin filament 
formation by fluorescence microscopy (Figure 22B). The percentage of NIH3T3 cells 
displaying nuclear actin structures mediated by INF2-DAD-core-NLS was reduced 
dramatically upon co-expression with hINF2-DID-NLS. However, this reduction could 
not be obtained upon transfection with the impaired DAD binding mutant hINF2-DID-
A149D-NLS.  
Furthermore, INF2 knockdown by siRNA in NIH3T3 cells led to a significant decrease of 
cells showing nuclear actin structures after transfection with INF2-DAD-core-NLS 
(Figure 22C). However, actin filaments in the nucleus could still be detected in a 
remarkable amount of cells. This could be explained by inhomogeneous siRNA 
mediated INF2 depletion within all analyzed cell. Thus, nuclear F-actin assembly upon 
INF2-DAD-core-NLS expression was analyzed in CRISPR/Cas9 mediated INF2 deleted 
NIH3T3 cells. Interestingly, even a complete knockout of INF2 did not entirely inhibit 
INF2-DAD-core-NLS driven formation of nuclear actin structures (Figure 22D). The 
results were rather comparable to the siINF2 knockdown cells.  
Worth mentioning, mutations of highly conserved INF2-FH2 residues (I643A and/or 
K792A) (Andrés-Delgado et al., 2010; Ramabhadran et al., 2012), which were shown to 
be essential for barbed end binding and actin polymerization in other formins 
(Shimada et al., 2004; Xu et al., 2004), did not abolish INF2-DAD-core-NLS mediated 
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nuclear actin filament formation but rather led to the formation of thick nucleus 
spanning actin bundles (Data not shown).  
 
Figure 22: Nuclear actin network assembly mediated by INF2-DAD depends on endogenous INF2 
A) SRF mediated transcription was measured in HEK cells transfected with either INF2-core-NLS or 
hINF2-DID-NLS alone or co-transfected with INF2-DAD-core-NLS together with equal amounts of hINF2-
DID-NLS. Results are means ± SD (n=3). **: P<0.01, ***: P<0.001, Student’s t-test. B) NIH3T3 cells 
expressing nAC-GFP together with BFP-INF2-DAD-core-NLS and either mCherry-NLS (as control), 
mCherry-hINF2-DID-NLS or hINF2-DID-A149D-NLS were analyzed and quantified in terms of nuclear 
actin filament formation. Only cells expressing both BFP-INF2-DAD-core-NLS and the hINF2-DID derivate 
were considered for quantification. Around 110 to 190 cells were analyzed for each condition in two 
independent experiments. *: P<0.05, **: P<0.01, Student’s t-test. C) INF2 silenced NIH3T3 cells were 
quantified for showing formation of INF2-DAD-core-NLS mediated nuclear actin filaments (visualized by 
co-transfection with nAC-GFP), compared to siControl cells. Only cells expressing mCherry-hINF2-DAD-
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core-NLS were considered for quantification. Around 90 to 120 cells were analyzed for each condition in 
two independent experiments. *: P<0.05, Student’s t-test. D) INF2 deleted NIH3T3 cells showing INF2-
DAD-core-NLS-mediated nuclear actin filaments were quantified and compared to NIH3T3 CRISPR 
control cells. Around 60 to 140 cells were analyzed for each condition in two independent experiments. 
*: P<0.05, Student’s t-test.  
 
4.4.4 Activation of endogenous INF2 partially modulates the activity of mDia1/2 
formins 
Depletion of INF2 did not fully inhibit INF2-DAD-core mediated effects, leading to the 
assumption that some of the effects might be, at least partially, unspecific, e. g. due to 
interaction or activation of other actin nucleators such as other formins. For example, 
INF2-DID has been shown to directly interact with the DAD of mDia proteins  and 
thereby plays a role in modulation of mDia mediated Rho signaling and SRF activity 
(Sun et al., 2014; Sun et al., 2011) as well as in the regulation of stable microtubules 
(Bartolini et al., 2016).  
Double-knockdown of mDia1 and mDia2 diminished the formation of nuclear actin 
filaments upon transfection with INF2-DAD-core-NLS (Figure 23A), although the effect 
was very minor compared to knockdown of INF2. Interestingly, triple-knockdown of 
INF2, together with mDia1 and mDia2 did not significantly further reduce INF2-DAD-
core-NLS mediated formation of nuclear F-actin when compared to INF2 alone (Figure 
23A, compare to Figure 22C). Double- and triple-knockdown efficiency was proven by 
immunoblotting (Figure 23A, upper panel). 
Also a complete CRISPR/Cas9 mediated INF2 deletion in NIH3T3 cells did not 
completely inhibit INF2-DAD-core-NLS driven formation of nuclear actin structures 
(Figure 23B). Furthermore, double-knockdown of mDia1 and mDia2 in CRISPR/Cas9 
control cells showed a moderate reduction in nuclei containing F-actin structures 
compared to siControl cells. INF2-depleted clones treated with simDia1 and simDia2 
did not display significant reduction of cells showing nuclear actin filaments as 
detected upon INF2-depletion alone (Figure 23B).  
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Figure 23: Active INF2 mediated nuclear F-actin assembly is partially modulated through mDia 
A) Upper panel:  Immunoblots for INF2, mDia1 and mDia2 from siRNA treated cells. Lower panel: 
simDia1/simDia2 or siINF2/simDia1/simDia2 treated NIH3T3 cells were transfected with INF2-DAD-core-
NLS and quantified in terms of nuclear actin filament formation. Around 100 to 170 cells were analyzed 
for each condition in two independent experiments. *: P<0.05, Student’s t-test. B) Upper panel: 
Immunoblots for INF2, mDia1 and mDia2 from siRNA treated INF2 depleted cells. Lower panel: INF2 
depleted NIH3T3 cells were treated with siRNA against mDia1 and mDia2. Cells expressing INF2-DAD-
core-NLS were quantified concerning the formation of F-actin in the nucleus. Around 130 to 230 cells 
were analyzed for each condition in two independent experiments. ns: P>0.05, *: P<0.05, Student’s t-
test.  
Additionally, we examined if the proposed INF2–mDia interaction (Sun et al., 2011) 
also influences hINF2-DID or INF2-DAD mediated effects on SRF activity. An increase in 
SRF activity upon expression of either mDia2-DAD or hINF2-DID alone could be 
compromised upon expression of both constructs together. In contrast, mDia2-DID and 
hiNF2-DAD co-expression showed an additive upregulation in MRTF/SRF 
transcriptional activity (Figure 24A). Similar tendencies in alterations of SRF activity 
were obtained using nuclear localized DID/DAD derivatives (Figure 24B).  
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INF2-DAD-core-NLS mediated nuclear F-actin formation was dramatically reduced 
upon co-expression with hINF2-DID-NLS (Figure 22B). In contrast, co-expression of 
INF2-DAD-core-NLS with either mDia1-DID-NLS or mDia2-DID-NLS resulted only in a 
minor reduction of cells displaying an INF2-DAD-core-NLS induced nuclear actin 
network compared to control cells (Figure 24C). According to the assumption that 
INF2-DAD induced effects on actin filament formation are partially caused by 
interaction with mDia proteins, expressing a dominant negative (dn) form of mDia, 
which is deficient in binding of the FH2 domain to actin, should reduce the number of 
cells showing INF2-DAD driven rearrangement of the actin cytoskeleton. Therefore, 
nuclear mDia1-I845R (Shimada et al., 2004) or mDia2-I704A (Harris et al., 2006) was 
expressed together with INF2-DAD-core-NLS in NIH3T3 cells and the number of 
transfected cells with visible nuclear actin filaments was determined. However, neither 
dn-mDia1-NLS nor dn-mDia2-NLS expression significantly depleted the percentage of 
cells displaying a nuclear actin network compared to control cells (Figure 24C). 
 
 90 
 
Figure 24: mDia2-DAD interferes with INF2-DID mediated SRF modulation 
A) MRTF/SRF transcriptional activity was measured in HEK cells transfected with either mDia2-DAD or 
mINF2-DID alone or co-transfected with mDia2-DAD together with equal amounts of mINF2-DID. A 
similar experiment was conducted in HEK cells expressing mDia2-DID or INF2-DAD-core or both 
constructs together. Results are means ± SD (n=3). **: P<0.01, ****: P<0.0001, Student’s t-test. B) As 
(A), but cells were transfected with the respective NLS tagged DID or DAD versions. Results are means ± 
SD (n=3). *: P<0.05, ***: P<0.001, Student’s t-test. C) NIH3T3 cells expressing nAC-GFP together with 
BFP-INF2-DAD-core-NLS and either mCherry-NLS, mCherry-mDia1-DID-NLS, mCherry-mDia2-DID-NLS, 
RFP-mDia1-I845R-NLS or RFP-mDia2-I704A-NLS were analyzed and quantified in terms of nuclear actin 
filament formation. Only cells expressing all constructs were considered for quantification. Around 100 
to 170 cells were analyzed for each condition in two independent experiments. ns: P>0.05, *: P<0.05, 
Student’s t-test.  
Taken together, these results suggest that active endogenous INF2, besides its direct 
impact on actin rearrangement, also partially modulates the activity of mDia1/2 
formins. This modulation also occurs in the nuclear compartment.  
 
4.4.5 Spatiotemporal activation of endogenous INF2 by a photoactivatable LOV-INF2-
DAD/WH2 fusion protein mediates nuclear accumulation of MRTF-A and induces 
nuclear actin filament formation 
The sustained presence of a formin induced nuclear actin network, for instance 
mediated INF2-DAD-core-NLS expression, might lead to unexpected and unwanted 
functional and morphological impacts on cells. Thus, an optogenetic tool, was 
introduced to activate endogenous INF2 in a spatially and temporally regulated 
manner to avoid potential unwanted effects in further experiments. The main idea, 
based on previous approaches to generate photoactivatable DADs of mDia1 or mDia2 
(Baarlink et al., 2013; Rao et al., 2013), was that the photoactivatable LOV (light, 
oxygen, voltage) Jα-domain (aa 403-543) of Avena sativa phototropin-1 (AsLOV2) 
(Harper et al., 2003) was fused to the DAD of INF2, thereby inhibiting its binding 
properties of INF2-DAD to endogenous INF2 when the LOV domain is in its closed 
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conformation. Upon illumination with blue light, unwinding of the Jα-helix would 
subsequently release inhibition of the DAD, leading to activation of INF2.  
To achieve this, the LOV domain was fused to INF2-DAD/WH2, a region within INF2-
DAD-core, possessing similar features as INF2-DAD-core in terms of influencing SRF 
activity or driving nuclear actin filament formation when targeted to the nucleus.  
Initially a series of derivatives was generated containing successive truncations at the 
N-terminus of INF2-DAD/WH2 (Figure 25A). To validate successful caching of INF2 
DAD/WH2 activity, these INF2-DAD/WH2 derivatives were fused to a light-insensitive 
‘dark-state’ version of AsLOV2, containing the point mutation C450A (Harper et al., 
2003), and SRF activity was measured upon transfection of cells with the respective 
construct. The expression of the constructs starting with aa 967, 968, 969, 970 and 971 
caused only a minor activation of MRTF-SRF transcription, hence arguing for successful 
INF2-DAD/WH2 caging (Figure 25B). The selected ‘dark-state’ LOV-INF2-DAD/WH2 
constructs (967, 968, 969, 970 and 971) were then compared to their ‘lit-state’ 
counterparts, mimicking the permanently unfolded state of the LOV domain. The ‘lit-
state’ of AsLOV2 is characterized by the point mutation I539E in the Jα helix (Harper et 
al., 2004). INF2-DAD/WH2 derivatives 969, 970 and 971 thereby demonstrated the 
most significant variance in the extent of MRTF-SRF transcriptional regulation 
comparing ‘dark state’ vs. ‘lit state’ (Figure 25C). Alterations in SRF activity were 
accompanied by accumulation of MRTF-A in the nucleus upon photoactivation of LOV-
INF2-DAD/WH2 by illumination of cells with blue LED for 3h (Figure 25D). 
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Figure 25: Screening for a photoactivatable LOV-INF2-DAD/WH2 fusion protein  
A) Cartoon illustrating the suggested ability of LOV2 fused to INF2-DAD/WH2 to activate endogenous 
INF2 by light irradiation. The LOV2 domain of phototropin1 consists of a Per-ARNT-Sim (PAS) domain 
and a C-terminal Jα-helix. Upon illumination with blue light, which leads to unfolding of the Jα-helix, the 
INF2-DAD/WH2 domain is subsequently uncaged. The magnification shows a scheme of different LOV-
INF2-DAD/WH2 constructs, which were generated by fusion of the LOV2 domain to successive N-
terminal truncations of the INF2-DAD/WH2 domain (shown in red). Numbers indicate the positions of 
amino acid residues in hINF2. Numbers in bold represent the truncations which showed the most 
promising differences in SRF activity when comparing the respective ‘lit state’ construct (LOV2 mutation 
I539E) compared to its ‘dark state’ counterpart (LOV2 mutation C450A) (cf. Figure 25C). B) HEK cells 
expressing ‘dark state’ mutants of different LOV-INF2-DAD/WH2 fusion proteins were analyzed for their 
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ability to stimulate SRF transcriptional activity to define a subset of constructs showing successful 
caching of the DAD/WH2 domain. The expression of INF2-DAD/WH2 serves as negative control. Results 
are means ± SD (n=3). C) MRTF/SRF activity was analyzed in HEK cells transfected with selected ‘lit state’ 
LOV-INF2-DAD/WH2 constructs compared to their ‘dark state’ counterparts. Results are means ± SD 
(n=3). D) Images show NIH3T3 cells expressing mCherry-LOV-INF2-DAD/WH2-971 together with MRTF-
A-GFP. Images were taken before and after 3 hours of blue LED illumination. Scale bar, 10 µm. 
Photoactivatable release of INF2 autoinhibition restricted to the nucleus was obtained 
by fusing an NLS to LOV-GS-INF2-DAD/WH2-971 (containing an additional GS-linker 
sequence between the LOV-domain and INF2-DAD/WH2 starting with aa 971) (Figure 
26A). A remarkable increase in the number of LOV-GS-INF2-DAD/WH2-971-NLS 
transfected cells containing nuclear F-actin structures could be visualized upon 
illumination of cells for 3 hours with blue LED (Figure 26B).  
 
Figure 26: Spatiotemporal release of INF2 autoinhibition by using an optogenetic tool induces nuclear 
actin filament formation  
A) Model illustrating a nuclear photoactivatable INF2-DAD/WH2 construct. An additional GS linker 
sequence between the LOV2 domain and INF2-DAD/WH2-NLS was inserted. B) nAC-GFP and mCherry-
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LOV-GS-INF2-DAD/WH2-971-NLS co-transfected NIH3T3 cells were quantified in terms of showing 
nuclear actin filaments (right panel). Images were taken before and after illumination for 3 hours with 
blue LED. Around 60 to 110 cells were analyzed for each condition in two independent experiments. Left 
panel: Images display representative cells before and after illumination. Scale bar, 10 µm.  
 
4.4.6 The dynamics of INF2-DAD mediated nuclear actin network formation 
The formation of a prominent nuclear F-actin network mediated by photoactivatable 
nuclear mDia2-DAD was initiated already within a few minutes upon intervallic 
irradiation with 488 nm using confocal microscopy (Baarlink et al., 2013). However, 
investigating the dynamics of nuclear actin filament formation by utilization of LOV-GS-
INF2-DAD/WH2-971-NLS did not reveal visible nuclear F-actin within this short range of 
time. In contrast, nuclear actin rearrangement did not occur before around one hour 
of constant illumination with blue LED. Thus, it was impossible to visualize nuclear 
actin rearrangement live by confocal microscope, as upon this rather long period of 
continuous illumination cycles the fluorescent signal of nAC-GFP was already bleached.  
Generally, active INF2 in the cytoplasm did not result in nuclear actin network 
assembly (Figure 27A, B). To analyze the dynamics of INF2-DAD-core-NLS mediated 
release of INF2 autoinhibition in the nucleus and subsequent nuclear actin filament 
formation, two NES and one NLS was fused to obtain NES-mCherry-NES-INF2-DAD-
core-NES-NLS (Figure 27C). This construct was supposed to continuously shuttle 
between the cytoplasm and the nucleus in a CRM1 dependent manner, displaying the 
majority of the protein localized to the cytoplasm under steady state conditions. 
Indeed, treatment of cells with 25 nM LMB resulted in a rapid accumulation of NES-
mCherry-NES-INF2-DAD-core-NES-NLS in the nuclear compartment within a few 
minutes. However, de novo generation of nuclear actin filaments could be detected 
around 15 to 30 minutes upon LMB treatment. Around 1 hour after addition of LMB, 
nuclei finally showed the INF2-DAD-core-NLS mediated characteristic actin pattern 
(Figure 27D). In contrast, nuclear F-actin formation occurred already within a few 
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minutes upon LMB mediated nuclear translocation of mDia2-DAD (Baarlink et al., 
2013).  
 
Figure 27: The dynamics of nuclear F-actin assembly mediated by INF2-DAD 
A-B) Images show NIH3T3 cells with active INF2 (either achieved (A) by expression of constitutive active 
hINF2 or hINF2-CAAX or (B) by expression of the respective hINF2-DAD isoform) were co-transfected 
with nAC as marker for nuclear actin and analyzed for the formation of nuclear actin filaments. Scale 
bar, 10 µm. C) Model of a nucleocytoplasmic shuttling INF2-DAD-core construct. Different NES (NES*: 
NES of STAT3 - SLAAEFRHLQLK, NES**: NES of HIV-Rev - LPPLERLTL) and the NLS from the SV40 large T 
antigen (PPKKKRKV) were added to obtain NES-mCherry-NES-INF2-DAD-core-NES-NLS. D) NIH3T3 cells 
expressing NES-mCherry-NES-INF2-DAD-core-NES-NLS together with nAC-GFP were treated with 25 nM 
LMB and monitored over time. Representative video stills display dynamic nuclear accumulation of NES-
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mCherry-NES-INF2-DAD-core-NES-NLS upon LMB treatment and subsequent spatiotemporal nuclear F-
actin assembly. Scale bar, 10 µm. 
However, LMB treatment leads to accumulation of a wide variety of different proteins 
in the nucleus. Thus, to exclude the possibility that nuclear actin filament formation is 
mediated by other factors than INF2-DAD, a nucleocytoplasmic shuttling version of the 
DID binding deficient mutant INF2-DAD-core-3LtoA was generated. Interestingly, no 
nuclear actin network could be detected in most cells upon LMB mediated nuclear 
translocation of NES-mCherry-NES-INF2-DAD-core-3LtoA-NES-NLS to the nucleus 
(Figure 28A, B). 
 
Figure 28: Actin filament formation in the nucleus upon LMB treatment depends on INF2-DAD 
expression  
A) The images show representative NES-mCherry-NES-INF2-DAD-core-NES-NLS and nAC-GFP expressing 
cells after 1.5 h after addition of 25 nM LMB. B) NIH3T3 cells expressing NES-mCherry-NES-INF2-DAD-
core-NES-NLS were quantified in terms of visible nuclear actin structures before and upon treatment 
with 25 nM LMB. nAC-GFP was used as marker for nuclear actin. Around 60 to 120 cells were analyzed 
for each condition.  
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5. Discussion 
While the appearance of monomeric or short oligomeric actin in the nucleus and its 
role in processes like general transcriptional regulation or chromatin remodeling has 
been described previously (de Lanerolle and Serebryannyy, 2011; Gieni and Hendzel, 
2009; Percipalle, 2013), the existence and functions of F-actin in somatic cell nuclei 
remained widely enigmatic (Pederson, 2008; Pederson and Aebi, 2002). However, 
recent work has provided visual evidence for endogenous polymeric and filamentous 
actin structures in the nucleus in both, fixed and living mammalian cells (Baarlink et al., 
2013; Belin et al., 2013; Plessner et al., 2015). Additionally, several regulatory proteins 
involved in actin polymerization, such as the ARP2/3 complex (Yoo et al., 2007), N-
WASP (Suetsugu and Takenawa, 2003) or members of the formin family (Belin et al., 
2015; Miki et al., 2009; Ménard et al., 2006; Stüven et al., 2003) have been detected 
inside the nucleus and some of their nuclear functions have already been described. 
For example, our group has shown in a previous study that nuclear mDia activity 
regulates the SRF coactivator MRTF-A (Baarlink et al., 2013), an integral transcriptional 
cofactor, which is directly controlled by actin dynamics (Olson and Nordheim, 2010).  
In general, to analyze formin mediated actin dynamics a directed regulation of formin 
autoinhibition and resultant formin activity is crucial. Former studies achieved spatially 
and/or temporally regulated activity of mDia formins by expression of the isolated DAD 
peptide which was shown to interfere with the intramolecular DID/DAD binding and 
consequently with the autoinhibited state of the formin (Alberts, 2001; Baarlink et al., 
2013; Rao et al., 2013). The major advantage of this system is the exclusive modulation 
of the endogenous formin as there is no use to overexpress the full length protein or 
even a constitutively active version. In contrast, a putative disadvantage could be that 
the DID and DAD regions among certain formin families show highly conserved 
elements. Thus, cross-activation of related formins cannot be excluded and has not 
been intensely tested so far. In this study we expand the toolbox to activate 
endogenous mDia by demonstrating a successful autoinhibition release upon the 
expression of a peptide composed of the isolated fi
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motif. Furthermore, a modification in the activity status of formins by expression of 
isolated DAD or DID peptides was not restricted to mDia formins but could also be 
implemented in at least INF2.  
It was shown recently, that INF2 modulates MRTF/SRF transcriptional activity in a Ca2+ 
dependent manner, distinct from Rho, ROCK and mDia mediated SRF activation (Wales 
et al., 2016). In this work, the ability to regulate INF2 in a controlled manner led 
further to the discovery that actin rearrangement driven by INF2-DID or INF2-DAD 
expression results in a potent modulation of MRTF/SRF transcriptional activity. 
Additionally, we adduce evidence that INF2 plays an essential role in the physiological 
serum response in cells, as a depletion of INF2 strikingly impeded SRF activity induced 
by serum. Moreover, we provide additional layers of complexity concerning the 
assembly of nuclear F-actin structures and resultant MRTF-A/SRF regulation. In 
particular, a small but distinct amount of INF2 could be biochemically identified in 
nuclear fractions. The nuclear localization of endogenous INF2 was additionally 
confirmed by confocal microscopy. Concomitantly, the activation of endogenous INF2 
restricted to the nuclear compartment results in nuclear actin filament formation. INF2 
mediated F-actin assembly in the nucleus was followed by nuclear accumulation of 
MRTF-A and subsequent regulation of MRTF/SRF transcriptional activity. Hence, it can 
be hypothesized that in general the cellular actin response to serum and other stimuli 
depends on a tightly regulated signaling network. It involves a complex interplay of 
numerous factors, including the formin INF2, spanning from receptors at the cell 
surface which transmit extracellular cues up to transcription factors regulating gene 
expression in the nuclear compartment. 
Previous studies have indicated DID/DAD interactions between closely related formins 
with the ability to regulate their activity in trans (Copeland et al., 2007; Sun et al., 
2011; Vaillant et al., 2008). Thus, another important part of this study was to reveal if 
the effects on actin rearrangement and SRF activity mediated by the expression of 
INF2-DID or INF2-DAD are the result of direct interference with the autoinhibition of 
endogenous INF2 or rather due to an impact on other actin nucleation factors. 
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Addressing this question, multiple aspects in terms of specific modulation of 
endogenous INF2 autoinhibition were investigated.  
The two INF2 isoforms in mammalian cells were shown to differ in their far C-terminus, 
which is dependent for its cellular localization (Chhabra et al., 2009; Ramabhadran et 
al., 2011). Here, we could show that the expression of the isoform specific INF2 C-
terminus (including the DAD) promotes the assembly of differential actin patterns 
which resemble the identical phenotype as achieved upon expression of the respective 
full length constitutive active INF2 isoform (Ramabhadran et al., 2013). Thus, we 
suggest that INF2-DAD interferes with DID/DAD binding of INF2 and subsequently 
activates endogenous INF2. INF2 activation can be obtained in an isoform- and thus 
site-specific manner, leading to the formation of distinct F-actin phenotypes.  
Worth mentioning, the DAD of INF2 resembles a WH2 motif and was reported to 
sequester actin monomers. However, polymerization activity has not been reported 
for the isolated C-terminus of INF2, which includes the DAD/WH2 domain (Chhabra 
and Higgs, 2006). Thus, and because of the fact that INF2 contains only a single G-actin 
binding WH2 motif, we propose that the re-organization of cytoplasmic and nuclear F-
actin upon INF2-DAD expression is mediated rather by activation of the endogenous 
formin than by a hypothetic intrinsic actin nucleation activity of the WH2 domain upon 
binding to G-actin. Theoretically, it could also be hypothesized that visible actin 
structures are simply the result of site-specific accumulation of actin monomers bound 
to the WH2 domain of INF2. In our study we refute this assumption as hINF2-DAD or 
especially hINF2-DAD-CAAX promoted cytoplasmic F-actin structures as well as INF2-
DAD-core-NLS driven nuclear actin filaments can clearly be visualized in fixed cells by 
phalloidin staining. Phalloidin was shown to exclusively bind F-actin and not G-actin 
with high affinity (Vandekerckhove et al., 1985; Wulf et al., 1979). Furthermore, the 
pattern of nuclear INF2-DAD mediated F-actin does not resemble the pattern of the 
expressed INF2-DAD-core-NLS, which is diffusely distributed within the nuclear 
compartment.  
 100 
 
In contrast to wild type INF2-DAD-core, the expression of INF2-DAD-core featuring a 
triple Leucine to Alanine mutation (3LtoA) (Chhabra and Higgs, 2006) did not drive 
MRTF/SRF transcriptional activity. These mutations, all residing in the INF2-DAD/WH2 
domain, were characterized to abrogate binding of the WH2 motif to actin monomers 
and inhibit actin severing and depolymerization activity of INF2 (Chhabra and Higgs, 
2006; Ramabhadran et al., 2012). Moreover, they prevent DID-DAD binding, thus 
blocking the autoinhibitory interaction of INF2 (Chhabra et al., 2009). Worth 
mentioning, a recent study showed a competitive G-actin binding between the RPEL 
motifs of MRTF-A and different WH2 domains isolated from N-WASP, WAVE2, Spire2 
or Cobl, resulting in activation of MRTF-A/SRF transcriptional activity. This WH2 
domain mediated alteration of SRF activity was shown to occur independently of their 
role in actin filament formation (Weissbach et al., 2016). Thus, we cannot completely 
rule out an at least partial impact of the isolated INF2-DAD or more precisely of its 
intrinsic WH2 domain on the modulation of MRTF-A/SRF activity by competitive 
binding to G-actin. However, we detected a striking impairment of MRTF-A 
translocation to the nucleus and reduced SRF activity in cells lacking INF2 upon 
expressing the DAD of INF2. Noteworthy, the impairment could at least partially be 
rescued by re-introducing full length INF2 into cells. This argues for a major 
contribution of endogenous INF2 to facilitate INF2-DAD driven effects on MRTF/SRF 
transcriptional activity rather than MRTF-A regulation by competitive binding of G-
actin to the INF2-DAD inhering WH2 motif.  
Additionally, we could also show that SRF activity driven by the expression of the 
isolated hINF2-DID gets diminished upon the introduction of diverse single point 
mutations to the DID construct (A149D, E184K or R218Q). These point mutations were 
shown to interfere with DID/DAD binding of INF2 (Brown et al., 2010; Ramabhadran et 
al., 2013; Rollason et al., 2016). Thus, we suggest that the mutated DID constructs are 
incapable of releasing INF2 autoinhibition. Interestingly, the point mutations E184K 
and R218Q were also described in cases of the renal disease FSGS (Brown et al., 2010).  
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Furthermore, we introduced the 3LtoA mutation in the nuclear targeted version of 
INF2-DAD-core. Thereby we revealed that the formation of a nuclear F-actin network 
cannot be detected upon expression of INF2-DAD-core-3LtoA-NLS. In contrast, the 
expression of unmodified INF2-DAD-core-NLS resulted in the assembly of nuclear actin 
filaments in the majority of transfected cells. Interestingly, INF2-DAD-core-NLS driven 
filament formation was frequently accompanied by the assembly of a very prominent 
actin ring-like structure partially colocalizing with the interior side of the nuclear 
lamina. We could determine that this actin ring is different from the INF2-CAAX 
mediated perinuclear actin ring. 
The fraction of cells displaying nuclear actin filaments upon INF2-DAD-core-NLS 
expression could be strikingly reduced upon co-expression with hINF2-DID-NLS but not 
with the DAD binding deficient mutant hINF2-DID-A149D-NLS. Thus we conclude that 
expression of the isolated DID peptide in part sterically interferes with binding of the 
expressed DAD (and vice versa) to the endogenous formin and thereby restricts 
release of formin autoinhibition. In accordance, co-expression of INF2-DID together 
with INF2-DAD-core also compensates for the effect on SRF activity compared to single 
expression of the respective proteins. 
Consistent with the assumption that expression of INF2-DAD-CAAX specifically affects 
the activity status of endogenous INF2-CAAX, a decreased amount of INF2 depleted 
cells showed formation of an active INF2-CAAX typical actin pattern after expression of 
hINF2-DAD-CAAX when compared to wild type cells. Additionally, the percentage of 
cells displaying INF2-DAD-core-NLS mediated nuclear actin filament formation was 
significantly reduced upon INF2 knockdown by siRNA. However, a distinct amount of 
siRNA mediated INF2 knockdown cells expressing INF2-DAD-core-NLS still showed 
nuclear actin filaments. The most plausible general explanation therefore would be 
that not all cells got affected by siRNA treatment. These cells would still express INF2 
and thus they are unimpededly able to form INF2 mediated F-actin in the nucleus. In 
turn, we also analyzed INF2-DAD-core-NLS mediated nuclear F-actin formation in cells 
completely lacking INF2 mediated by the CRISPR/CAS system. However, although 
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immunoblotting revealed a complete loss of INF2, a certain amount of INF2 knockout 
cells also still displayed nuclear actin structures in response to INF2-DAD expression. 
Taken together, this suggests that cells can either partially compensate for the loss of 
INF2 or that the INF2-DAD may functionally interact with other actin nucleation 
factors, probably with other related formins, at least in the nucleus.  
Noteworthy, a heterodimerization between closely related formins has been described 
in previous studies. For example, it was shown that heterodimerization of full-length 
mDia1 and mDia2 occurs by DID/DAD interaction but not by their dimerization motif 
and FH2 domain. This DID/DAD interaction is able to act in trans to inhibit formin 
activity (Copeland et al., 2007). In turn, in addition to a described DID/DAD interaction, 
also the FH2 and the dimerization domain of the formins FRL2 and FRL3 (also known as 
FMNL3 and FMNL2) are able to form hetero-oligomers (Vaillant et al., 2008).  
A recent study revealed that also the only partially related formins INF2 and mDia can 
form heterodimers via INF2-DID and mDia-DAD (Sun et al., 2011), Thus, we analyzed if 
co-expression of the DID and the DAD of either INF2 or mDia2 show additive or 
antagonistic effects in terms of their ability to activate MRTF/SRF mediated gene 
transcription. We revealed that co-expression of mDia2-DAD and mINF2-DID 
remarkably reduced SRF activity. This suggests mainly two possible scenarios: either 1) 
a direct interaction occurs between the overexpressed proteins and thereby 
preventing them to release autoinhibition of the respective endogenous formins, or 2) 
INF2-DID interferes with the autoinhibition of endogenous INF2 (or mDia), whereas 
mDia-DAD activates endogenous mDia (or INF2) but both active formins subsequently 
negatively regulate each other’s impact on actin rearrangement and SRF activity. The 
latter option has been described for mDia and INF2. It was discovered that INF2 
antagonizes Rho activated actin polymerization activity of mDia signaling by an 
interaction of INF2-DID with the DAD sequence of mDia1, mDia2 or mDia3 (Sun et al., 
2011). Furthermore, experiments in cultured podocytes as well as in vivo experiments 
revealed that active INF2 is an important antagonist of mDia1 and mDia2 mediated 
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actin dynamics, related to processes as the formation of lamellipodia and peripheral 
membrane trafficking (Sun et al., 2014; Sun et al., 2013).  
Contrariwise, co-expression of mDia2-DID together with INF2-DAD-core showed a 
synergistic effect in terms of SRF activation. Hence, we suggest, in contrast to mDia-
DAD and INF2-DID, that INF2-DAD does not directly interact with mDia-DID. Thus, they 
do not prevent each other from interfering with the autoinhibition of endogenous INF2 
of mDia. Moreover, endogenous active INF2 cannot antagonize mDia activity in this 
situation, as the intramolecular INF2-DID and mDia-DAD are occupied by the 
overexpressed INF2-DAD and mDia-DID, respectively.  
Furthermore, we investigated if the number of cells displaying a nuclear F-actin 
network upon expression of INF2-DAD-core-NLS gets reduced when cells co-express 
mDia1-DID or mDia2-DID. Indeed, the number of cells with visible nuclear actin 
structures was diminished, although to a much more moderate extent than upon co-
expression of INF2-DAD-core-NLS together with hINF2-DID. This suggests that 
expression of mDia1-DID or mDia2-DID interferes with INF2-DAD mediated activation 
of endogenous INF2. However, as a direct interaction between the DID of mDia 
formins and the DAD of INF2 was not reported (Sun et al., 2011), we hypothesize that 
both expressed constructs act independently from each other, thereby negatively 
modulating the formation of nuclear actin filaments. Hence, simultaneous nuclear 
activation of endogenous INF2 and endogenous mDia by INF2-DAD-core and mDia2-
DID might prevent each other from the formation of visible F-actin structures in the 
nucleus, although they do not counteract in terms of MRTF/SRF regulation.  
Moreover, co-expression of INF2-DAD-core-NLS together with nuclear targeted, 
dominant negative derivatives of mDia, mDia1-I845R (Shimada et al., 2004) or mDia2-
I704A (Harris et al., 2006) did neither alter the number of cells displaying INF2-DAD-
core-NLS mediated nuclear F-actin nor the actin pattern itself (data not shown). This 
result additionally underscores the hypothesis that INF2-DAD does not directly affect 
mDia mediated actin rearrangement. In turn we also analyzed the impact on nuclear 
full length INF2 derivatives possessing mutated FH2 residues (I643A and/or K792A) 
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(Andrés-Delgado et al., 2010; Ramabhadran et al., 2012). In other formins, the 
respective mutations were described to be essential for actin binding and 
polymerization (Shimada et al., 2004; Xu et al., 2004). Interestingly, nuclear expression 
of INF2-I643A, INF2-K792A or INF2-I643A/K792A in combination with INF2-DAD-core-
NLS did not abolish the formation of nuclear F-actin structures, but rather resulted in 
the formation of thick and elongated actin bundles (data not shown). This rather 
unforeseen phenotype can be explained by the multiple diverging effects described for 
these mutations in the FH2 domain of INF2.  A recent study has shown that INF2-I643A 
does not show decreased barbed end binding but that it rather causes tight capping of 
a subset of filaments. Furthermore, the I643A mutation possesses a minor inhibitory 
effect on actin polymerization activity but it causes almost a complete abolishment of 
severing and depolymerization activity. Also the INF2-K792A mutant affects both 
polymerization and severing/depolymerization activity, although to a much smaller 
degree than INF2-I643A. Moreover, INF2-K792A has similar barbed end affinity as wild 
type INF2, but it was shown to decelerate the rate of processive elongation 
(Ramabhadran et al., 2012). Therefore, we conclude that the formation of nuclear 
actin filaments mediated by INF2 activity is dependent on both, its polymerization as 
well as its depolymerization/severing capabilities.  
Furthermore, we analyzed if siRNA mediated depletion of mDia1 and mDia2 also 
affects the assembly of nuclear F-actin upon expression of INF2-DAD-core-NLS. Indeed, 
simultaneous suppression of both, mDia1 and mDia2, negatively influenced nuclear 
actin filaments triggered by expression of INF2-DAD, although to a much more 
moderate extent than INF2 knockdown and INF2 depletion does. Interestingly, 
simultaneous depletion of INF2 together with mDia1 and mDia2 also did not 
completely abolish INF2-DAD-core-NLS mediated nuclear F-actin formation but led to a 
similar result as INF2 depletion alone. These experiments provide evidence that by and 
large the effects of INF2-DAD seem to be specific for INF2 and are unlikely to occur 
mainly due to crosstalk with other formins. Thereby, we suggest that INF2-DAD 
interferes specifically with INF2 autoinhibition, whereas activated INF2 additionally 
seems to execute regulatory effects on nuclear F-actin formation through interaction 
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with mDia formins. Noteworthy, synergistic effects between INF2 and mDia have not 
been described so far, although they cannot be entirely ruled out. Moreover, our 
results also point towards a potential role for additional so far unidentified factors in 
INF2-mediated nuclear actin filament formation.  
In a nutshell, we discover here that the formin INF2 is an actin nucleation factor with 
the ability to form a nuclear actin network upon spatially restricted release of 
autoinhibition inside the nucleus. One direct consequence of nuclear INF2 activation is 
the translocation of the SRF cofactor MRTF-A to the nucleus followed by modulation of 
MRTF/SRF mediated gene transcription. Moreover, this work suggests a putative 
crosstalk between the formins INF2 and mDia as well as other unknown proteins inside 
the nuclear compartment. Thus, INF2 may play an important cellular role for fine-
tuning or adjusting the multiple and complex levels of signal regulations of MRTF-A 
(Panayiotou et al., 2016; Vartiainen et al., 2007). However, conducting follow-up 
studies on INF2 driven actin dynamics, it has to be generally kept in mind that INF2 
also possess a potent actin severing and depolymerization activity, thus massively 
broadening the scope for interpretations. Therefore, further studies have to be 
implemented addressing the exact cellular functions of nuclear INF2 together with the 
precise cross-regulation of other proteins.  
INF2 mediated regulation of actin turnover was suggested to be involved in diseases 
affecting the peripheral nervous system (CMT) and the kidney glomerulus (FSGS) 
(Boyer et al., 2011; Brown et al., 2010; Subramanian et al., 2016). All so far identified 
disease-causing point mutations reside in the DID of INF2. Some of them were shown 
to result in dysfunctional INF2 autoinhibition (Rollason et al., 2016) and in impaired 
INF2-DID/mDia-DAD interaction (Sun et al., 2014; Sun et al., 2013). Both effects were 
suggested to lead to imbalanced actin dynamics and disruption of actin based 
processes. Based on our findings that INF2 plays an essential role in the physiological 
serum response and that INF2 mediated nuclear F-actin formation is sufficient to drive 
MRTF/SRF transcriptional activity, a disease-relevant role for mutated INF2 in the 
nuclear compartment is hypothetically possible. For example, perturbed nuclear actin 
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rearrangement caused by mutated INF2 might alter the localization and activity of 
MRTF-A and thus leading to a deregulated transcription of SRF target genes. This 
deregulated MRTF/SRF transcriptional activity might theoretically contribute to the 
onset of FSGS or CMT.  
Another aspect which remains to be elucidated is the detailed transport mechanism 
which is in charge of regulating the hypothesized nuclear localization of INF2. Although 
formins such as mDia (Copeland et al., 2007; Miki et al., 2009) or FMN2 (Belin et al., 
2015), but also INF2, as we now revealed by subcellular fractionation experiments, can 
be detected in the nuclear compartment, they usually reside predominantly in the 
cytoplasm under steady-state conditions. Thus, we suggest that INF2 continuously 
undergoes nucleocytoplasmic shuttling, which occurs through either direct interaction 
of INF2 with the nuclear import or export machinery or through co-import and co-
export in a complex with other proteins.  
Continuous shuttling between the nuclear compartment and the cytoplasm has been 
recently shown for mDia1 and mDia2. To accomplish nuclear entry, full-length mDia2 
was suggested to bind directly to importin-α via an N-terminal bipartite NLS and gets 
imported into the nucleus by an importin-α/β complex (Miki et al., 2009). In turn, the 
nuclear import mechanism of mDia1 has not been fully characterized, although the 
protein was detected in nuclear fractions (Baarlink et al., 2013). A putative C-terminal 
NLS was reported for mDia1 (Copeland et al., 2007). However, whether this NLS is 
functional in full-length mDia1 remains to be tested. Moreover, mDia2, but not mDia1, 
was shown to be exported from the nucleus in a CRM1 dependent manner. It rapidly 
accumulates in the nucleus within minutes upon blocking CRM1-dependent nuclear 
export by using LMB (Miki et al., 2009). In contrast, mDia1 was speculated to become 
constantly co-exported with profilin and actin via an exportin 6 dependent pathway, as 
they appeared together in a purified nuclear exportin 6 complex (Stüven et al., 2003).  
Despite the detection of nuclear INF2 localization, we currently do not know by which 
mechanism INF2 is translocated to and from nucleus. Bioinformatic analysis of the 
hINF2 amino acid sequence revealed several putative NLS and NES sequences. At least 
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one of the detected putative NLS (termed NLS3) and NES (termed NES4) sequences 
was shown to be functional when the peptide was isolated and fused to GFP. 
Interestingly, expression of GFP-NES4 furthermore revealed nuclear enrichment upon 
treatment with LMB, thus its export is at least partially dependent on CRM1. However, 
it still has to be determined if NLS3 and NES4 are also functional in a full length 
context. We could already reveal that CRM1 mediated nuclear export does not seem 
to play a role in the shuttling of endogenous INF2 as treatment of cells with LMB did 
not result in nuclear accumulation of the full-length protein. Thus, we suggest that 
INF2 contains functional NLS and NES motifs to undergo continuous nucleocytoplasmic 
shuttling by using a so far unidentified nuclear transport machinery. It remains a future 
challenge to identify the detailed transport mechanisms which are in charge of 
regulating the nuclear entry and export of INF2.  
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